TW202336123A - Freshwater biodegradable mixed ester cellulose esters - Google Patents
Freshwater biodegradable mixed ester cellulose esters Download PDFInfo
- Publication number
- TW202336123A TW202336123A TW111143168A TW111143168A TW202336123A TW 202336123 A TW202336123 A TW 202336123A TW 111143168 A TW111143168 A TW 111143168A TW 111143168 A TW111143168 A TW 111143168A TW 202336123 A TW202336123 A TW 202336123A
- Authority
- TW
- Taiwan
- Prior art keywords
- film
- mce
- substituents
- substitution
- category
- Prior art date
Links
- 229920002678 cellulose Polymers 0.000 title claims abstract description 80
- 239000013505 freshwater Substances 0.000 title abstract description 7
- 150000002148 esters Chemical class 0.000 title description 13
- 239000006185 dispersion Substances 0.000 claims abstract description 10
- 238000006467 substitution reaction Methods 0.000 claims description 71
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 45
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 45
- 239000004014 plasticizer Substances 0.000 claims description 28
- 238000010998 test method Methods 0.000 claims description 12
- 125000003118 aryl group Chemical group 0.000 claims description 6
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 5
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims description 5
- XZZNDPSIHUTMOC-UHFFFAOYSA-N triphenyl phosphate Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)(=O)OC1=CC=CC=C1 XZZNDPSIHUTMOC-UHFFFAOYSA-N 0.000 claims description 4
- ASMQGLCHMVWBQR-UHFFFAOYSA-M diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)([O-])OC1=CC=CC=C1 ASMQGLCHMVWBQR-UHFFFAOYSA-M 0.000 claims description 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 4
- 239000000203 mixture Substances 0.000 abstract description 93
- -1 articles Substances 0.000 abstract description 64
- 239000011324 bead Substances 0.000 abstract description 14
- 239000010408 film Substances 0.000 description 57
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 39
- 238000000034 method Methods 0.000 description 25
- 238000012360 testing method Methods 0.000 description 25
- 229920002301 cellulose acetate Polymers 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- 239000003963 antioxidant agent Substances 0.000 description 21
- 239000000463 material Substances 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 20
- 238000006065 biodegradation reaction Methods 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 239000001913 cellulose Substances 0.000 description 17
- OMVSWZDEEGIJJI-UHFFFAOYSA-N 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate Chemical compound CC(C)C(=O)OC(C(C)C)C(C)(C)COC(=O)C(C)C OMVSWZDEEGIJJI-UHFFFAOYSA-N 0.000 description 16
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 239000002019 doping agent Substances 0.000 description 15
- 235000006708 antioxidants Nutrition 0.000 description 14
- 239000003921 oil Substances 0.000 description 14
- 235000019198 oils Nutrition 0.000 description 14
- 239000002904 solvent Substances 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 13
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 12
- 239000001301 oxygen Substances 0.000 description 12
- 229910052760 oxygen Inorganic materials 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 12
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 12
- YIMQCDZDWXUDCA-UHFFFAOYSA-N [4-(hydroxymethyl)cyclohexyl]methanol Chemical compound OCC1CCC(CO)CC1 YIMQCDZDWXUDCA-UHFFFAOYSA-N 0.000 description 11
- 239000012528 membrane Substances 0.000 description 11
- 229920001223 polyethylene glycol Polymers 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- 239000003381 stabilizer Substances 0.000 description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 9
- 239000000945 filler Substances 0.000 description 9
- 239000000049 pigment Substances 0.000 description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- 229940121375 antifungal agent Drugs 0.000 description 8
- 229910002092 carbon dioxide Inorganic materials 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000002480 mineral oil Substances 0.000 description 8
- 235000010446 mineral oil Nutrition 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000002202 Polyethylene glycol Substances 0.000 description 7
- 239000000654 additive Substances 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 239000011325 microbead Substances 0.000 description 7
- 125000001424 substituent group Chemical group 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 229920000426 Microplastic Polymers 0.000 description 5
- 229920002988 biodegradable polymer Polymers 0.000 description 5
- 239000004621 biodegradable polymer Substances 0.000 description 5
- 235000019439 ethyl acetate Nutrition 0.000 description 5
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 235000010216 calcium carbonate Nutrition 0.000 description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000036284 oxygen consumption Effects 0.000 description 4
- 229920001610 polycaprolactone Polymers 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- AYEKOFBPNLCAJY-UHFFFAOYSA-O thiamine pyrophosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N AYEKOFBPNLCAJY-UHFFFAOYSA-O 0.000 description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical group CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 229920008347 Cellulose acetate propionate Polymers 0.000 description 3
- 241000272194 Ciconiiformes Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000004927 clay Substances 0.000 description 3
- 229910052570 clay Inorganic materials 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000003475 lamination Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 125000005498 phthalate group Chemical class 0.000 description 3
- 229920000747 poly(lactic acid) Polymers 0.000 description 3
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000000807 solvent casting Methods 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 239000001069 triethyl citrate Substances 0.000 description 3
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 3
- 235000013769 triethyl citrate Nutrition 0.000 description 3
- XMAYWYJOQHXEEK-ZEQKJWHPSA-N (2S,4R)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@H]1O[C@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-ZEQKJWHPSA-N 0.000 description 2
- JLGKQTAYUIMGRK-UHFFFAOYSA-N 1-{2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=1C2=CC=CC(Cl)=C2SC=1)CN1C=NC=C1 JLGKQTAYUIMGRK-UHFFFAOYSA-N 0.000 description 2
- SQKUFYLUXROIFM-UHFFFAOYSA-N 2-[2-[carboxymethyl-[[3-hydroxy-2-methyl-5-(phosphonooxymethyl)pyridin-4-yl]methyl]amino]ethyl-[[3-hydroxy-2-methyl-5-(phosphonooxymethyl)pyridin-4-yl]methyl]amino]acetic acid Chemical compound CC1=NC=C(COP(O)(O)=O)C(CN(CCN(CC(O)=O)CC=2C(=C(C)N=CC=2COP(O)(O)=O)O)CC(O)=O)=C1O SQKUFYLUXROIFM-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 2
- 101100439208 Caenorhabditis elegans cex-1 gene Proteins 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 2
- 229930183931 Filipin Natural products 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 239000004609 Impact Modifier Substances 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- ZFOZVQLOBQUTQQ-UHFFFAOYSA-N Tributyl citrate Chemical compound CCCCOC(=O)CC(O)(C(=O)OCCCC)CC(=O)OCCCC ZFOZVQLOBQUTQQ-UHFFFAOYSA-N 0.000 description 2
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 2
- 244000290333 Vanilla fragrans Species 0.000 description 2
- 235000009499 Vanilla fragrans Nutrition 0.000 description 2
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 229920000704 biodegradable plastic Polymers 0.000 description 2
- YHASWHZGWUONAO-UHFFFAOYSA-N butanoyl butanoate Chemical compound CCCC(=O)OC(=O)CCC YHASWHZGWUONAO-UHFFFAOYSA-N 0.000 description 2
- 239000000292 calcium oxide Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 230000009920 chelation Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- MQHNKCZKNAJROC-UHFFFAOYSA-N dipropyl phthalate Chemical compound CCCOC(=O)C1=CC=CC=C1C(=O)OCCC MQHNKCZKNAJROC-UHFFFAOYSA-N 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- IMQSIXYSKPIGPD-NKYUYKLDSA-N filipin Chemical compound CCCCC[C@H](O)[C@@H]1[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@H](O)\C(C)=C\C=C\C=C\C=C\C=C\[C@H](O)[C@@H](C)OC1=O IMQSIXYSKPIGPD-NKYUYKLDSA-N 0.000 description 2
- 229950000152 filipin Drugs 0.000 description 2
- IMQSIXYSKPIGPD-UHFFFAOYSA-N filipin III Natural products CCCCCC(O)C1C(O)CC(O)CC(O)CC(O)CC(O)CC(O)CC(O)C(C)=CC=CC=CC=CC=CC(O)C(C)OC1=O IMQSIXYSKPIGPD-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000001087 glyceryl triacetate Substances 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- 229910002804 graphite Inorganic materials 0.000 description 2
- 239000010439 graphite Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 150000002432 hydroperoxides Chemical class 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- PXZQEOJJUGGUIB-UHFFFAOYSA-N isoindolin-1-one Chemical compound C1=CC=C2C(=O)NCC2=C1 PXZQEOJJUGGUIB-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 235000014380 magnesium carbonate Nutrition 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 239000004311 natamycin Substances 0.000 description 2
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 2
- 235000010298 natamycin Nutrition 0.000 description 2
- 229960003255 natamycin Drugs 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000012436 odor-modifying agent Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 2
- 229920009537 polybutylene succinate adipate Polymers 0.000 description 2
- 239000004632 polycaprolactone Substances 0.000 description 2
- 208000034301 polycystic dysgenetic disease of parotid salivary glands Diseases 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 238000000935 solvent evaporation Methods 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 2
- FUSNMLFNXJSCDI-UHFFFAOYSA-N tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- MGMXGCZJYUCMGY-UHFFFAOYSA-N tris(4-nonylphenyl) phosphite Chemical compound C1=CC(CCCCCCCCC)=CC=C1OP(OC=1C=CC(CCCCCCCCC)=CC=1)OC1=CC=C(CCCCCCCCC)C=C1 MGMXGCZJYUCMGY-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 239000004034 viscosity adjusting agent Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical class [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 2
- BLSQLHNBWJLIBQ-OZXSUGGESA-N (2R,4S)-terconazole Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2N=CN=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 BLSQLHNBWJLIBQ-OZXSUGGESA-N 0.000 description 1
- MPIPASJGOJYODL-SFHVURJKSA-N (R)-isoconazole Chemical compound ClC1=CC(Cl)=CC=C1[C@@H](OCC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 MPIPASJGOJYODL-SFHVURJKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZCJYUTQZBAIHBS-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)benzyl]oxy}ethyl]imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=1C=CC(SC=2C=CC=CC=2)=CC=1)CN1C=NC=C1 ZCJYUTQZBAIHBS-UHFFFAOYSA-N 0.000 description 1
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 description 1
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 1
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 1
- QXHHHPZILQDDPS-UHFFFAOYSA-N 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound S1C=CC(COC(CN2C=NC=C2)C=2C(=CC(Cl)=CC=2)Cl)=C1Cl QXHHHPZILQDDPS-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- BUNYVNKRMVBHDG-UHFFFAOYSA-N 2,2,4,4,6,6-hexamethyl-3-propan-2-ylheptanedioic acid Chemical compound OC(=O)C(C)(C)C(C(C)C)C(C)(C)CC(C)(C)C(O)=O BUNYVNKRMVBHDG-UHFFFAOYSA-N 0.000 description 1
- RNFJDJUURJAICM-UHFFFAOYSA-N 2,2,4,4,6,6-hexaphenoxy-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene Chemical compound N=1P(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP=1(OC=1C=CC=CC=1)OC1=CC=CC=C1 RNFJDJUURJAICM-UHFFFAOYSA-N 0.000 description 1
- NOGFHTGYPKWWRX-UHFFFAOYSA-N 2,2,6,6-tetramethyloxan-4-one Chemical compound CC1(C)CC(=O)CC(C)(C)O1 NOGFHTGYPKWWRX-UHFFFAOYSA-N 0.000 description 1
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
- AIBRSVLEQRWAEG-UHFFFAOYSA-N 3,9-bis(2,4-ditert-butylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC=C1OP1OCC2(COP(OC=3C(=CC(=CC=3)C(C)(C)C)C(C)(C)C)OC2)CO1 AIBRSVLEQRWAEG-UHFFFAOYSA-N 0.000 description 1
- SSADPHQCUURWSW-UHFFFAOYSA-N 3,9-bis(2,6-ditert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane Chemical compound CC(C)(C)C1=CC(C)=CC(C(C)(C)C)=C1OP1OCC2(COP(OC=3C(=CC(C)=CC=3C(C)(C)C)C(C)(C)C)OC2)CO1 SSADPHQCUURWSW-UHFFFAOYSA-N 0.000 description 1
- IFBHRQDFSNCLOZ-IIRVCBMXSA-N 4-nitrophenyl-α-d-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C([N+]([O-])=O)C=C1 IFBHRQDFSNCLOZ-IIRVCBMXSA-N 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 108010064760 Anidulafungin Proteins 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- KAWOEDMUUFFXAM-UHFFFAOYSA-N CC1(C)CCCC2(C)C(C)C(C=O)=CCC21 Polymers CC1(C)CCCC2(C)C(C)C(C=O)=CCC21 KAWOEDMUUFFXAM-UHFFFAOYSA-N 0.000 description 1
- LMHKYRHXXIQSKL-UHFFFAOYSA-N CCCCC(O)=O.OC(=O)CC(O)(CC(O)=O)C(O)=O Chemical compound CCCCC(O)=O.OC(=O)CC(O)(CC(O)=O)C(O)=O LMHKYRHXXIQSKL-UHFFFAOYSA-N 0.000 description 1
- 101100439211 Caenorhabditis elegans cex-2 gene Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 108010020326 Caspofungin Proteins 0.000 description 1
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- ASMQGLCHMVWBQR-UHFFFAOYSA-N Diphenyl phosphate Chemical class C=1C=CC=CC=1OP(=O)(O)OC1=CC=CC=C1 ASMQGLCHMVWBQR-UHFFFAOYSA-N 0.000 description 1
- 108010049047 Echinocandins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- 239000004181 Flavomycin Substances 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 229910019440 Mg(OH) Inorganic materials 0.000 description 1
- 108010021062 Micafungin Proteins 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- OLUNPKFOFGZHRT-YGCVIUNWSA-N Naftifine hydrochloride Chemical compound Cl.C=1C=CC2=CC=CC=C2C=1CN(C)C\C=C\C1=CC=CC=C1 OLUNPKFOFGZHRT-YGCVIUNWSA-N 0.000 description 1
- JKIJEFPNVSHHEI-UHFFFAOYSA-N Phenol, 2,4-bis(1,1-dimethylethyl)-, phosphite (3:1) Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC=C1OP(OC=1C(=CC(=CC=1)C(C)(C)C)C(C)(C)C)OC1=CC=C(C(C)(C)C)C=C1C(C)(C)C JKIJEFPNVSHHEI-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- RZKYEQDPDZUERB-UHFFFAOYSA-N Pindone Chemical group C1=CC=C2C(=O)C(C(=O)C(C)(C)C)C(=O)C2=C1 RZKYEQDPDZUERB-UHFFFAOYSA-N 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- AZJUJOFIHHNCSV-KCQAQPDRSA-N Polygodial Polymers C[C@@]1([C@H](C(C=O)=CC2)C=O)[C@@H]2C(C)(C)CCC1 AZJUJOFIHHNCSV-KCQAQPDRSA-N 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- NRCMAYZCPIVABH-UHFFFAOYSA-N Quinacridone Chemical compound N1C2=CC=CC=C2C(=O)C2=C1C=C1C(=O)C3=CC=CC=C3NC1=C2 NRCMAYZCPIVABH-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ZIJKGAXBCRWEOL-SAXBRCJISA-N Sucrose octaacetate Chemical compound CC(=O)O[C@H]1[C@H](OC(C)=O)[C@@H](COC(=O)C)O[C@@]1(COC(C)=O)O[C@@H]1[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1 ZIJKGAXBCRWEOL-SAXBRCJISA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 229920002522 Wood fibre Polymers 0.000 description 1
- 239000001344 [(2S,3S,4R,5R)-4-acetyloxy-2,5-bis(acetyloxymethyl)-2-[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyoxolan-3-yl] acetate Substances 0.000 description 1
- TYBHXIFFPVFXQW-UHFFFAOYSA-N abafungin Chemical compound CC1=CC(C)=CC=C1OC1=CC=CC=C1C1=CSC(NC=2NCCCN=2)=N1 TYBHXIFFPVFXQW-UHFFFAOYSA-N 0.000 description 1
- 229950006373 abafungin Drugs 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 229920003232 aliphatic polyester Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 229910000287 alkaline earth metal oxide Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005257 alkyl acyl group Chemical group 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- JHVAMHSQVVQIOT-MFAJLEFUSA-N anidulafungin Chemical compound C1=CC(OCCCCC)=CC=C1C1=CC=C(C=2C=CC(=CC=2)C(=O)N[C@@H]2C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N3C[C@H](C)[C@H](O)[C@H]3C(=O)N[C@H](O)[C@H](O)C2)[C@@H](C)O)[C@H](O)[C@@H](O)C=2C=CC(O)=CC=2)[C@@H](C)O)=O)C=C1 JHVAMHSQVVQIOT-MFAJLEFUSA-N 0.000 description 1
- 229960003348 anidulafungin Drugs 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 125000005251 aryl acyl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- PERZMHJGZKHNGU-JGYWJTCASA-N bambermycin Chemical compound O([C@H]1[C@H](NC(C)=O)[C@@H](O)[C@@H]([C@H](O1)CO[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1NC(C)=O)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@H](O1)C(=O)NC=1C(CCC=1O)=O)O)C)[C@H]1[C@@H](OP(O)(=O)OC[C@@H](OC\C=C(/C)CC\C=C\C(C)(C)CCC(=C)C\C=C(/C)CCC=C(C)C)C(O)=O)O[C@H](C(O)=O)[C@@](C)(O)[C@@H]1OC(N)=O PERZMHJGZKHNGU-JGYWJTCASA-N 0.000 description 1
- AYJRCSIUFZENHW-DEQYMQKBSA-L barium(2+);oxomethanediolate Chemical compound [Ba+2].[O-][14C]([O-])=O AYJRCSIUFZENHW-DEQYMQKBSA-L 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000000981 basic dye Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 150000008641 benzimidazolones Chemical class 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229960002206 bifonazole Drugs 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000003842 bromide salts Chemical class 0.000 description 1
- 229960002962 butenafine Drugs 0.000 description 1
- ABJKWBDEJIDSJZ-UHFFFAOYSA-N butenafine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)CC1=CC=C(C(C)(C)C)C=C1 ABJKWBDEJIDSJZ-UHFFFAOYSA-N 0.000 description 1
- 229960005074 butoconazole Drugs 0.000 description 1
- SWLMUYACZKCSHZ-UHFFFAOYSA-N butoconazole Chemical compound C1=CC(Cl)=CC=C1CCC(SC=1C(=CC=CC=1Cl)Cl)CN1C=NC=C1 SWLMUYACZKCSHZ-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- PTOJXIKSKSASRB-UHFFFAOYSA-O candicine Chemical compound C[N+](C)(C)CCC1=CC=C(O)C=C1 PTOJXIKSKSASRB-UHFFFAOYSA-O 0.000 description 1
- 150000001716 carbazoles Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- JYIKNQVWKBUSNH-WVDDFWQHSA-N caspofungin Chemical compound C1([C@H](O)[C@@H](O)[C@H]2C(=O)N[C@H](C(=O)N3CC[C@H](O)[C@H]3C(=O)N[C@H](NCCN)[C@H](O)C[C@@H](C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N2)[C@@H](C)O)=O)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@H](O)CCN)=CC=C(O)C=C1 JYIKNQVWKBUSNH-WVDDFWQHSA-N 0.000 description 1
- 229960003034 caspofungin Drugs 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- SCKYRAXSEDYPSA-UHFFFAOYSA-N ciclopirox Chemical compound ON1C(=O)C=C(C)C=C1C1CCCCC1 SCKYRAXSEDYPSA-UHFFFAOYSA-N 0.000 description 1
- 229960003749 ciclopirox Drugs 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009264 composting Methods 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960003913 econazole Drugs 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 229940041693 ertaczo Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- UXOLDCOJRAMLTQ-UHFFFAOYSA-N ethyl 2-chloro-2-hydroxyiminoacetate Chemical compound CCOC(=O)C(Cl)=NO UXOLDCOJRAMLTQ-UHFFFAOYSA-N 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960001274 fenticonazole Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 235000019374 flavomycin Nutrition 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000010794 food waste Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000012760 heat stabilizer Substances 0.000 description 1
- RBTKNAXYKSUFRK-UHFFFAOYSA-N heliogen blue Chemical compound [Cu].[N-]1C2=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=NC([N-]1)=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=N2 RBTKNAXYKSUFRK-UHFFFAOYSA-N 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229960000788 isavuconazole Drugs 0.000 description 1
- DDFOUSQFMYRUQK-RCDICMHDSA-N isavuconazole Chemical compound C=1SC([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC=C(F)C=2)F)=NC=1C1=CC=C(C#N)C=C1 DDFOUSQFMYRUQK-RCDICMHDSA-N 0.000 description 1
- 229960004849 isoconazole Drugs 0.000 description 1
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical compound C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 description 1
- 229960004130 itraconazole Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 229940089474 lamisil Drugs 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229940098895 maleic acid Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- PIEUQSKUWLMALL-YABMTYFHSA-N micafungin Chemical compound C1=CC(OCCCCC)=CC=C1C1=CC(C=2C=CC(=CC=2)C(=O)N[C@@H]2C(N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N3C[C@H](C)[C@H](O)[C@H]3C(=O)N[C@H](O)[C@H](O)C2)[C@H](O)CC(N)=O)[C@H](O)[C@@H](O)C=2C=C(OS(O)(=O)=O)C(O)=CC=2)[C@@H](C)O)=O)=NO1 PIEUQSKUWLMALL-YABMTYFHSA-N 0.000 description 1
- 229960002159 micafungin Drugs 0.000 description 1
- 229940101563 micatin Drugs 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012764 mineral filler Substances 0.000 description 1
- 239000007003 mineral medium Substances 0.000 description 1
- 239000000983 mordant dye Substances 0.000 description 1
- 229960004313 naftifine Drugs 0.000 description 1
- OZGNYLLQHRPOBR-DHZHZOJOSA-N naftifine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)C\C=C\C1=CC=CC=C1 OZGNYLLQHRPOBR-DHZHZOJOSA-N 0.000 description 1
- 229940100527 naftin Drugs 0.000 description 1
- NSNPSJGHTQIXDO-UHFFFAOYSA-N naphthalene-1-carbonyl chloride Chemical class C1=CC=C2C(C(=O)Cl)=CC=CC2=C1 NSNPSJGHTQIXDO-UHFFFAOYSA-N 0.000 description 1
- OBJNZHVOCNPSCS-UHFFFAOYSA-N naphtho[2,3-f]quinazoline Chemical class C1=NC=C2C3=CC4=CC=CC=C4C=C3C=CC2=N1 OBJNZHVOCNPSCS-UHFFFAOYSA-N 0.000 description 1
- 229940064438 nizoral Drugs 0.000 description 1
- 239000012788 optical film Substances 0.000 description 1
- 239000012766 organic filler Substances 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 229940039748 oxalate Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229960003483 oxiconazole Drugs 0.000 description 1
- QRJJEGAJXVEBNE-MOHJPFBDSA-N oxiconazole Chemical compound ClC1=CC(Cl)=CC=C1CO\N=C(C=1C(=CC(Cl)=CC=1)Cl)\CN1C=NC=C1 QRJJEGAJXVEBNE-MOHJPFBDSA-N 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical class N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 239000002745 poly(ortho ester) Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- FPGPDEPMWUWLOV-UHFFFAOYSA-N polygodial Natural products CC1(C)CCCC2(C)C(C=O)C(=CC(O)C12)C=O FPGPDEPMWUWLOV-UHFFFAOYSA-N 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229960001589 posaconazole Drugs 0.000 description 1
- RAGOYPUPXAKGKH-XAKZXMRKSA-N posaconazole Chemical compound O=C1N([C@H]([C@H](C)O)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@H]3C[C@@](CN4N=CN=C4)(OC3)C=3C(=CC(F)=CC=3)F)=CC=2)C=C1 RAGOYPUPXAKGKH-XAKZXMRKSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- FYNROBRQIVCIQF-UHFFFAOYSA-N pyrrolo[3,2-b]pyrrole-5,6-dione Chemical compound C1=CN=C2C(=O)C(=O)N=C21 FYNROBRQIVCIQF-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 229940051201 quinoline yellow Drugs 0.000 description 1
- 239000004172 quinoline yellow Substances 0.000 description 1
- 235000012752 quinoline yellow Nutrition 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 239000012783 reinforcing fiber Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 150000003336 secondary aromatic amines Chemical class 0.000 description 1
- 229960005429 sertaconazole Drugs 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000012748 slip agent Substances 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 238000007655 standard test method Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- UVGUPMLLGBCFEJ-SWTLDUCYSA-N sucrose acetate isobutyrate Chemical compound CC(C)C(=O)O[C@H]1[C@H](OC(=O)C(C)C)[C@@H](COC(=O)C(C)C)O[C@@]1(COC(C)=O)O[C@@H]1[C@H](OC(=O)C(C)C)[C@@H](OC(=O)C(C)C)[C@H](OC(=O)C(C)C)[C@@H](COC(C)=O)O1 UVGUPMLLGBCFEJ-SWTLDUCYSA-N 0.000 description 1
- 239000001797 sucrose acetate isobutyrate Substances 0.000 description 1
- 235000010983 sucrose acetate isobutyrate Nutrition 0.000 description 1
- 229940013883 sucrose octaacetate Drugs 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- 229960000580 terconazole Drugs 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- JOUDBUYBGJYFFP-FOCLMDBBSA-N thioindigo Chemical compound S\1C2=CC=CC=C2C(=O)C/1=C1/C(=O)C2=CC=CC=C2S1 JOUDBUYBGJYFFP-FOCLMDBBSA-N 0.000 description 1
- 229940035290 tinactin Drugs 0.000 description 1
- 229960004214 tioconazole Drugs 0.000 description 1
- 229960004880 tolnaftate Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000005532 trapping Effects 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 1
- YZWRNSARCRTXDS-UHFFFAOYSA-N tripropionin Chemical compound CCC(=O)OCC(OC(=O)CC)COC(=O)CC YZWRNSARCRTXDS-UHFFFAOYSA-N 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000012855 volatile organic compound Substances 0.000 description 1
- 229960004740 voriconazole Drugs 0.000 description 1
- BCEHBSKCWLPMDN-MGPLVRAMSA-N voriconazole Chemical compound C1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)=NC=NC=C1F BCEHBSKCWLPMDN-MGPLVRAMSA-N 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 238000004927 wastewater treatment sludge Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000002025 wood fiber Substances 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/10—Esters of organic acids, i.e. acylates
- C08L1/14—Mixed esters, e.g. cellulose acetate-butyrate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B3/00—Preparation of cellulose esters of organic acids
- C08B3/16—Preparation of mixed organic cellulose esters, e.g. cellulose aceto-formate or cellulose aceto-propionate
- C08B3/18—Aceto-butyrates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/08—Cellulose derivatives
- C08L1/10—Esters of organic acids, i.e. acylates
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
Landscapes
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Cosmetics (AREA)
- Biological Depolymerization Polymers (AREA)
Abstract
Description
在自然環境中,習知的不可生物降解塑膠機械地分解成在環境中持續之小片塑膠(稱為微塑膠)。一些單次使用塑膠,諸如用於健康及美容產品之微珠粒,及來自衣物之棉絨微纖維為其他微塑膠源。由於其大小,此等微塑膠最終進入天然水體。為減少微塑膠產生,需要使用淡水可生物降解之塑膠。In the natural environment, conventional non-biodegradable plastics mechanically break down into small pieces of plastic (called microplastics) that persist in the environment. Some single-use plastics, such as microbeads used in health and beauty products, and lint microfibers from clothing are other sources of microplastics. Due to their size, these microplastics end up in natural bodies of water. To reduce the production of microplastics, freshwater biodegradable plastics need to be used.
申請人揭示混合酯乙酸丙酸纖維素及混合酯乙酸丁酸纖維素聚合物,其已設計成具有乙醯基、丙醯基/丁酸酯及羥基含量之適當混合物以在淡水環境中生物降解。本文中所揭示之混合酯纖維素酯適用於製備淡水可生物降解之膜、微珠粒及其他製品。Applicants disclose mixed ester cellulose acetate propionate and mixed ester cellulose acetate butyrate polymers that have been designed to have appropriate mixtures of acetyl, propyl/butyrate and hydroxyl contents to biodegrade in freshwater environments . The mixed ester cellulose esters disclosed herein are suitable for use in the preparation of freshwater biodegradable films, microbeads, and other products.
本申請案揭示一種混合酯纖維素酯(「MCE」),其包含: (1)複數個乙醯基取代基; (2)複數個丙醯基取代基;及 (3)複數個羥基取代基, 其中: 該MCE對於該等乙醯基取代基的取代度(「DS Ac」)為0.6至1.9, 該MCE對於該等丙醯基取代基的取代度(「DS Pr」)為0.5至0.95, 該MCE對於該等羥基取代基的取代度(「DS OH」)為0.7至1.4。 This application discloses a mixed ester cellulose ester ("MCE"), which contains: (1) a plurality of acetyl substituents; (2) a plurality of propyl substituents; and (3) a plurality of hydroxyl substituents , wherein: the degree of substitution of the MCE for the acetyl substituents ("DS Ac ") is 0.6 to 1.9, and the degree of substitution of the MCE for the propyl substituents ("DS Pr ") is 0.5 to 0.95 , the degree of substitution (“DS OH ”) of the MCE for the hydroxyl substituents is 0.7 to 1.4.
本申請案亦揭示一種混合纖維素酯(「MCE」),其包含: (1)複數個乙醯基取代基; (2)複數個丙醯基取代基;及 (3)複數個羥基取代基, 其中: 該MCE對於該等乙醯基取代基的平均取代度(「DS Ac」)為0.6至1.2, 該MCE對於該等丙醯基取代基的平均取代度(「DS Pr」)為1.05至1.4,且 該MCE對於該等羥基取代基的平均取代度(「DS OH」)為0.7至1.4。 This application also discloses a mixed cellulose ester ("MCE"), which contains: (1) a plurality of acetyl substituents; (2) a plurality of propyl substituents; and (3) a plurality of hydroxyl substituents , where: the average degree of substitution of the MCE for the acetyl substituents ("DS Ac ") is 0.6 to 1.2, and the average degree of substitution of the MCE for the propyl substituents ("DS Pr ") is 1.05 to 1.4, and the average degree of substitution ("DS OH ") of the MCE for the hydroxyl substituents is 0.7 to 1.4.
本申請案亦揭示一種混合纖維素酯(「MCE」),其包含: (1)複數個乙醯基取代基; (2)複數個丁醯基取代基;及 (3)複數個羥基取代基, 其中: 該MCE對於該等乙醯基取代基的平均取代度(「DS Ac」)為0.9至2.4, 該MCE對於該等丁醯基取代基的平均取代度(「DS Bu」)為0.1至1.1, 該MCE對於該等羥基取代基的平均取代度(「DS OH」)為0.6至1.5。 The present application also discloses a mixed cellulose ester ("MCE"), which contains: (1) a plurality of acetyl substituents; (2) a plurality of butyl substituents; and (3) a plurality of hydroxyl substituents, wherein : The average degree of substitution of the MCE for the acetyl substituents ("DS Ac ") is 0.9 to 2.4, the average degree of substitution of the MCE for the butyl substituents ("DS Bu ") is 0.1 to 1.1, the The average degree of substitution ("DS OH ") of MCE for these hydroxyl substituents is 0.6 to 1.5.
本申請案亦揭示由本文中所揭示之混合酯組合物製成之組合物、製品、珠粒、珠粒組合物及膜。This application also discloses compositions, articles, beads, bead compositions, and films made from the mixed ester compositions disclosed herein.
本申請案亦揭示由纖維素酯組合物形成之纖維素酯粒子,該纖維素酯組合物包含: (I)混合纖維素酯(「MCE」),其包含: (1)複數個乙醯基取代基; (2)複數個(C 2-3)烷基-CO-取代基;及 (3)複數個羥基取代基, 其中: 該MCE對於該等乙醯基取代基的平均取代度(「DS Ac」)為0.6至2.4, 該MCE對於該等(C 2-3)烷基-CO-取代基的平均取代度(「DS AkCO」)為0.1至1.1, 該MCE對於該等羥基取代基的平均取代度(「DS OH」)為0.55至1.5;及 (II)乙酸纖維素(「CA」),其包含: (1) 複數個乙醯基取代基;及 (2) 複數個羥基取代基, 其中: 該CA對於該等乙醯基取代基的平均取代度(「DS Ac」)為1.5至2.6, 該CA對於該等羥基取代基的平均取代度(「DS OH」)為0.4至1.5。 The present application also discloses cellulose ester particles formed from a cellulose ester composition, the cellulose ester composition comprising: (I) Mixed cellulose ester ("MCE"), which includes: (1) A plurality of acetyl groups substituents; (2) a plurality of (C 2-3 )alkyl-CO- substituents; and (3) a plurality of hydroxyl substituents, where: the average degree of substitution of the MCE for the acetyl substituents (" DS Ac ”) is 0.6 to 2.4, the MCE has an average degree of substitution (“DS AkCO ”) for the (C 2-3 )alkyl-CO- substituents of 0.1 to 1.1, and the MCE has an average degree of substitution for the hydroxyl substituents The average degree of substitution ("DS OH ") is 0.55 to 1.5; and (II) cellulose acetate ("CA"), which contains: (1) a plurality of acetyl substituents; and (2) a plurality of hydroxyl substitutions group, wherein: the average degree of substitution of the CA for the acetyl substituents ("DS Ac ") is 1.5 to 2.6, and the average degree of substitution of the CA for the hydroxyl substituents ("DS OH ") is 0.4 to 0.4 to 2.6. 1.5.
本申請案亦揭示一種摻雜組合物,其包含: (A)纖維素酯組合物: (I)混合纖維素酯(「MCE」),其包含: (1)複數個乙醯基取代基; (2)複數個(C 2-3)烷基-CO-取代基;及 (3)複數個羥基取代基, 其中: 該MCE對於該等乙醯基取代基的平均取代度(「DS Ac」)為0.6至2.4, 該MCE對於該等(C 2-3)烷基-CO-取代基的平均取代度(「DS AkCO」)為0.1至1.1, 該MCE對於該等羥基取代基的平均取代度(「DS OH」)為0.55至1.5,及 (II)乙酸纖維素(「CA」),其包含: (1) 複數個乙醯基取代基;及 (2) 複數個羥基取代基, 其中: 該CA對於該等乙醯基取代基的平均取代度(「DS Ac」)為1.5至2.6, 該CA對於該等羥基取代基的平均取代度(「DS OH」)為0.4至1.5;及 (B)溶劑, 其中該溶劑包含: (1)水, (2)乙酸(C 1-2)烷酯,及 (3)(C 1-5)烷醇, 其中該摻雜組合物展現3000至9000 cP範圍內之黏度。 This application also discloses a doping composition, which includes: (A) cellulose ester composition: (I) mixed cellulose ester ("MCE"), which includes: (1) a plurality of acetyl substituents; (2) a plurality of (C 2-3 )alkyl-CO- substituents; and (3) a plurality of hydroxyl substituents, where: the average degree of substitution of the MCE for the acetyl substituents ("DS Ac " ) is 0.6 to 2.4, the MCE has an average degree of substitution ("DS AkCO ") for the (C 2-3 ) alkyl-CO- substituents of 0.1 to 1.1, the MCE has an average substitution for the hydroxyl substituents degree ("DS OH ") of 0.55 to 1.5, and (II) cellulose acetate ("CA"), which contains: (1) a plurality of acetyl substituents; and (2) a plurality of hydroxyl substituents, wherein : The average degree of substitution of the CA for the acetyl substituents (“DS Ac ”) is 1.5 to 2.6, and the average degree of substitution of the CA for the hydroxyl substituents (“DS OH ”) is 0.4 to 1.5; and (B) A solvent, wherein the solvent includes: (1) water, (2) (C 1-2 ) alkyl acetate, and (3) (C 1-5 ) alkanol, wherein the doping composition exhibits a temperature range of 3000 to Viscosity in the 9000 cP range.
藉由參考以下本發明之詳細描述及其中提供之實例可更易於理解本發明。應理解,本發明不限於所描述之特定方法、調配物及條件,因而可變化。亦應理解,本文中所使用之術語僅出於描述本發明之特定態樣之目的,並且不意欲為限制性的。 The present invention may be more readily understood by reference to the following detailed description of the invention and the examples provided therein. It is to be understood that this invention is not limited to the particular methods, formulations and conditions described, as such may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular aspects of the invention only and is not intended to be limiting.
值可表示為「約(about)」或「大致(approximately)」給定數目。類似地,範圍可在本文中表示為「約」一個特定值及/或至「約」或另一特定值。當表示此類範圍時,另一態樣包括一個特定值及/或至另一特定值。類似地,當藉由使用字首「約」將值表示為近似值時,應瞭解,特定值形成另一態樣。Values can be expressed as "about" or "approximately" a given number. Similarly, ranges may be expressed herein as "about" one particular value and/or to "about" or another particular value. When such a range is expressed, another aspect includes one particular value and/or to the other particular value. Similarly, when a value is expressed as an approximation by use of the prefix "about," it should be understood that the particular value takes another form.
如本文中所使用,術語「一(a)」、「一(an)」及「該(the)」意謂一或多個。 As used herein, the terms "a", "an" and "the" mean one or more.
如本文中所使用,當用於兩個或更多個項目之清單中時,術語「及/或(and/or)」意謂可採用所列項目中之任一者本身,或可採用所列項目中之兩者或更多者之任何組合。舉例而言,若將組合物描述為含有組分A、B及/或C,則組合物可單獨含有A、單獨含有B、單獨含有C;含有A及B之組合;含有A及C之組合;含有B及C之組合;或含有A、B及C之組合。 As used herein, the term "and/or" when used in a list of two or more items means that either one of the listed items may be employed by itself, or that all may be employed. Any combination of two or more of the listed items. For example, if a composition is described as containing components A, B, and/or C, the composition may contain A alone, B alone, C alone; a combination of A and B; a combination of A and C. ; A combination containing B and C; or a combination containing A, B and C.
如本文中所使用,術語「包含(comprising)」、「包含(comprises)」及「包含(comprise)」為開放式轉換術語,其用於將在該術語之前敍述之主題轉換成在該術語之後敍述的一或多個元素,其中在轉換術語之後列出的一或多個元素不一定為構成主題的唯一元素。 As used herein, the terms "comprising," "comprises," and "comprise" are open-ended conversion terms used to convert subject matter stated before the term to after the term. One or more elements of a narrative, where the one or more elements listed after the transition term are not necessarily the only elements that make up the subject matter.
如本文中所使用,術語「具有(having)」、「具有(has)」及「具有(have)」具有與上文所提供之「包含(comprising)」、「包含(comprises)」及「包含(comprise)」相同的開放式意義。 As used herein, the terms "having", "has" and "have" have the same meaning as "comprising", "comprises" and "comprises" as provided above. (comprise)" the same open meaning.
如本文中所使用,術語「包括(including)」、「包括(includes)」及「包括(include)」具有與上文所提供之「包含(comprising)」、「包含(comprises)」及「包含(comprise)」相同的開放式意義。 As used herein, the terms "including", "includes" and "include" have the same meaning as "comprising", "comprises" and "includes" provided above. (comprise)" the same open meaning.
「取代度(Degree of Substitution)」用於描述每脫水葡萄糖單元(「AGU」)的取代基的平均取代程度。一般而言,習知纖維素在各AGU中含有三個可經取代之羥基。因此,DS可具有0與3之間的值。然而,低分子量纖維素混合酯可因端基作用而具有略高於3之總取代度。在本揭示中隨後更詳細地論述低分子量纖維素混合酯。由於DS為統計平均值,故值1並不確保每一AGU具有單個取代基。在一些情況下,可存在未經取代的脫水葡萄糖單元,其中一些具有兩個取代基且一些具有三個取代基,且通常情況下,值將為非整數。總DS定義為每脫水葡萄糖單元之所有取代基之平均數目。每AGU之取代度亦可指特定取代基,諸如羥基、乙醯基、丁醯基或丙醯基。另外,取代度可指定基於脫水葡萄糖單元之碳單元的給定羥基。"Degree of Substitution" is used to describe the average degree of substitution of a substituent per anhydroglucose unit ("AGU"). Generally speaking, conventional cellulose contains three optionally substituted hydroxyl groups in each AGU. Therefore, DS can have values between 0 and 3. However, low molecular weight cellulose mixed esters may have a total degree of substitution slightly higher than 3 due to end group effects. Low molecular weight cellulose mixed esters are discussed in greater detail subsequently in this disclosure. Since DS is a statistical mean, a value of 1 does not ensure that each AGU has a single substituent. In some cases, unsubstituted anhydroglucose units may be present, some with two substituents and some with three substituents, and generally the values will be non-integer numbers. Total DS is defined as the average number of all substituents per anhydroglucose unit. The degree of substitution per AGU may also refer to specific substituents, such as hydroxy, acetyl, butyl, or propyl. Additionally, the degree of substitution may specify a given hydroxyl group based on the carbon unit of the anhydroglucose unit.
當取代度係指羥基(亦即,DS OH)時,係指每脫水葡萄糖之未經取代的平均羥基。因此,DS OH不用於計算總取代度。 When the degree of substitution refers to hydroxyl groups (ie, DS OH ), it refers to the average unsubstituted hydroxyl groups per anhydroglucose. Therefore, DS OH is not used in calculating the total degree of substitution.
數值範圍 本發明描述使用數值範圍來對與本發明有關之某些參數進行定量。應理解,在提供數值範圍時,此類範圍應解釋為提供文字支援以主張僅敍述該範圍之下限值的限制以及主張僅敍述該範圍之上限值的限制。舉例而言,所揭示之10至100之數值範圍提供文字支援以主張敍述「大於10」(不具有上限)及主張敍述「小於100」(不具有下限)。 Numeric range The present description uses numerical ranges to quantify certain parameters relevant to the present invention. It will be understood that where numerical ranges are provided, such ranges should be construed as providing textual support for asserting limitations that recite only the lower end of the range and for asserting limitations that recite only the upper end of the range. For example, the disclosed numerical range of 10 to 100 provides textual support for the assertion that the recitation is "greater than 10" (without an upper limit) and for the assertion that the recitation is "less than 100" (without a lower limit).
本說明書使用特定數值以對與本發明有關之某些參數進行定量,其中特定數值不明確地為數值範圍之一部分。應理解,本文中所提供之各特定數值應解釋為提供用於寬、中間及窄範圍之文字支援。與各特定數值相關聯之寬範圍為數值加減該數值之60%,四捨五入至兩個有效數位。與各特定數值相關聯之中間範圍為數值加減該數值之30%,四捨五入至兩個有效數位。與各特定數值相關聯之窄範圍為數值加減該數值之15%,四捨五入至兩個有效數位。舉例而言,若本說明書描述62℉之特定溫度,則此類描述為以下各項提供文字支援:25℉至99℉ (62℉ +/- 37℉)之寬數值範圍、43℉至81℉ (62℉ +/- 19℉)之中間數值範圍及53℉至71℉ (62℉ +/- 9℉)之窄數值範圍。此等寬、中間及窄數值範圍應不僅應用於特定值,且亦應應用於此等特定值之間的差。因此,若本說明書描述110 psia之第一壓力及48 psia之第二壓力(62 psi之差),則此兩個流之間的壓力差的寬、中間及窄範圍將分別為25至99 psi、43至81 psi及53至71 psi。 This specification uses specific numerical values, which are not explicitly part of a numerical range, to quantify certain parameters relevant to the present invention. It is understood that each specific numerical value provided herein should be interpreted as providing literal support for broad, intermediate and narrow ranges. The wide range associated with each specific numerical value is the numerical value plus or minus 60% of that value, rounded to two significant digits. The intermediate range associated with each specific numerical value is the numerical value plus or minus 30% of that value, rounded to two significant digits. The narrow range associated with each specific numerical value is the numerical value plus or minus 15% of that value, rounded to two significant digits. For example, if this specification describes a specific temperature of 62℉, such description provides textual support for: a wide numerical range of 25℉ to 99℉ (62℉ +/- 37℉), 43℉ to 81℉ The intermediate numerical range is (62℉ +/- 19℉) and the narrow numerical range is 53℉ to 71℉ (62℉ +/- 9℉). Such wide, intermediate and narrow numerical ranges shall apply not only to specific values, but also to differences between such specific values. Therefore, if this specification describes a first pressure of 110 psia and a second pressure of 48 psia (a difference of 62 psi), the wide, middle, and narrow ranges of the pressure difference between the two streams would be 25 to 99 psi respectively. , 43 to 81 psi and 53 to 71 psi.
貫穿本申請案,在參考專利或公開案之情況下,此等參考之揭示內容意欲以全文引用之方式併入本申請案中,其程度不與本發明不一致,以便更充分地描述本發明所涉及之目前先進技術。Throughout this application, where reference is made to a patent or publication, the disclosures of such references are intended to be incorporated by reference in their entirety into this application to the extent not inconsistent with the present invention in order to more fully describe the invention. Involves current advanced technology.
由此製備之纖維素酯通常包含以下結構: 其中R 2、R 3及R 6為氫(其限制條件為R 2、R 3及R 6不同時為氫)、烷基-醯基及/或芳基-醯基(諸如上文所描述之彼等),其經由酯鍵鍵結至纖維素。 The cellulose esters thus prepared generally contain the following structure: wherein R 2 , R 3 and R 6 are hydrogen (with the proviso that R 2 , R 3 and R 6 are not hydrogen at the same time), alkyl-acyl and/or aryl-acyl (such as those described above They), which are bonded to cellulose via ester bonds.
藉由此等方法製備之纖維素酯之聚合度(「DP」)可為至少10。在其他實施例中,纖維素酯之DP可為至少50、至少100或至少250。在其他實施例中,纖維素酯之DP可在約5至約100範圍內,或約10至約50範圍內。The degree of polymerization ("DP") of cellulose esters prepared by such methods can be at least 10. In other embodiments, the cellulose ester may have a DP of at least 50, at least 100, or at least 250. In other embodiments, the cellulose ester may have a DP in the range of about 5 to about 100, or in the range of about 10 to about 50.
適用於本文中之醯化試劑可包括但不限於含有上文所描述之烷基或芳基的烷基或芳基羧酸酐、羧酸鹵化物及/或羧酸酯,該等烷基或芳基適用於本文中所描述之經取代纖維素酯之醯基取代基。合適羧酸酐之實例包括但不限於乙酸酐、丙酸酐、丁酸酐、特戊醯基酸酐、苯甲酸酐及萘甲醯基酸酐。羧酸鹵化物之實例包括但不限於乙醯基、丙醯基、丁醯基、特戊醯基、苯甲醯基及萘甲醯基氯化物或溴化物。羧酸酯之實例包括但不限於乙醯基、丙醯基、丁醯基、特戊醯基、苯甲醯基及萘甲醯基甲酯。在一或多個實施例中,醯化試劑可為選自由以下各者組成之群的一或多種羧酸酐:乙酸酐、丙酸酐、丁酸酐、特戊醯基酸酐、苯甲醯基酸酐及萘甲醯基酸酐。Chelating agents suitable for use herein may include, but are not limited to, alkyl or aryl carboxylic acid anhydrides, carboxylic acid halides and/or carboxylic acid esters containing alkyl or aryl groups as described above. Suitable for acyl substituents of the substituted cellulose esters described herein. Examples of suitable carboxylic anhydrides include, but are not limited to, acetic anhydride, propionic anhydride, butyric anhydride, pivalyl anhydride, benzoic anhydride, and naphthoyl anhydride. Examples of carboxylic acid halides include, but are not limited to, acetyl, propionyl, butyl, pivalidyl, benzyl, and naphthoyl chlorides or bromides. Examples of carboxylic acid esters include, but are not limited to, acetyl, propylyl, butylyl, pivalyl, benzyl, and naphthylyl methyl esters. In one or more embodiments, the chelating agent may be one or more carboxylic anhydrides selected from the group consisting of: acetic anhydride, propionic anhydride, butyric anhydride, pivalyl anhydride, benzyl anhydride, and Naphthoyl anhydride.
在第一態樣中,本申請案揭示一種混合酯纖維素酯(「MCE」),其包含:(1)複數個乙醯基取代基;(2)複數個丙醯基取代基;及(3)複數個羥基取代基,其中:MCE對於乙醯基取代基的平均取代度(「DS Ac」)為0.6至2.3,MCE對於丙醯基取代基的平均取代度(「DS Pr」)為0.1至0.95,MCE對於羥基取代基的平均取代度(「DS OH」)為0.5至1.5。 In a first aspect, the present application discloses a mixed ester cellulose ester ("MCE") comprising: (1) a plurality of acetyl substituents; (2) a plurality of propyl substituents; and ( 3) A plurality of hydroxyl substituents, wherein: the average degree of substitution of MCE for the acetyl substituent ("DS Ac ") is 0.6 to 2.3, and the average degree of substitution of MCE for the propyl substituent ("DS Pr ") is 0.1 to 0.95, and the average degree of substitution of MCE for hydroxyl substituents (“DS OH ”) is 0.5 to 1.5.
在一個實施例中或與此第一態樣之任何其他實施例、類別或子類別組合,其中DS Ac為0.6至2.2,或0.6至2.1,或0.6至2.0,或0.6至1.9,或0.6至1.8,或0.7至2.3,或0.7至2.2,或0.7至2.1,或0.7至2.0,或0.7至1.9,或0.8至2.3,或0.8至2.2,或0.8至2.1,或0.8至2.0,或0.8至1.9,或0.9至2.3,或0.9至2.2,或0.9至2.1,或0.9至2.0,或0.9至1.9,或1.0至2.3或1.0至2.2,或1.0至2.1,或1.0至2.0,或1.0至1.9,或1.1至2.3,或1.1至2.2,或1.1至2.1,或1.1至2.0,或1.1至1.9,或1.2至2.3或1.2至2.2,或1.2至2.1,或1.2至2.0,或1.2至1.9,或0.6至1.5,或0.6至1.3,或0.6至1.1,或0.6至0.9或0.7至1.5,或0.7至1.3,或0.7至1.1,或0.7至0.9。 In one embodiment or any other embodiment, category or subcategory combination with this first aspect, wherein DS Ac is 0.6 to 2.2, or 0.6 to 2.1, or 0.6 to 2.0, or 0.6 to 1.9, or 0.6 to 1.8, or 0.7 to 2.3, or 0.7 to 2.2, or 0.7 to 2.1, or 0.7 to 2.0, or 0.7 to 1.9, or 0.8 to 2.3, or 0.8 to 2.2, or 0.8 to 2.1, or 0.8 to 2.0, or 0.8 to 1.9, or 0.9 to 2.3, or 0.9 to 2.2, or 0.9 to 2.1, or 0.9 to 2.0, or 0.9 to 1.9, or 1.0 to 2.3, or 1.0 to 2.2, or 1.0 to 2.1, or 1.0 to 2.0, or 1.0 to 1.9 , or 1.1 to 2.3, or 1.1 to 2.2, or 1.1 to 2.1, or 1.1 to 2.0, or 1.1 to 1.9, or 1.2 to 2.3, or 1.2 to 2.2, or 1.2 to 2.1, or 1.2 to 2.0, or 1.2 to 1.9, Or 0.6 to 1.5, or 0.6 to 1.3, or 0.6 to 1.1, or 0.6 to 0.9, or 0.7 to 1.5, or 0.7 to 1.3, or 0.7 to 1.1, or 0.7 to 0.9.
在一個實施例中或與此第一態樣之任何其他實施例、類別或子類別組合,其中DS Pr為0.1至0.9,或0.1至0.85,或0.1至0.8,或0.1至0.75,或0.1至0.7,或0.1至0.6或0.1至0.5,或0.1至0.4,或0.15至0.95,或0.15至0.9,或0.15至0.85,或0.15至0.8,或0.15至0.75,或0.15至0.7,或0.15至0.65,或0.2至0.95,或0.2至0.9,或0.2至0.85,或0.2至0.8,或0.2至0.75,或0.2至0.7,或0.2至0.65,0.25至0.95,或0.25至0.9,或0.25至0.85,或0.25至0.8,或0.25至0.75,或0.25至0.7,或0.25至0.65,或0.3至0.95,或0.3至0.9,或0.3至0.85,或0.3至0.8,或0.3至0.75,或0.3至0.7,或0.3至0.65,或0.35至0.95,或0.35至0.9,或0.35至0.85,或0.35至0.8,或0.35至0.75,或0.35至0.7,或0.35至0.65,或0.4至0.95,或0.4至0.9,或0.4至0.85,或0.4至0.8,或0.4至0.75,或0.4至0.7,或0.4至0.65,或0.45至0.95,或0.45至0.9,或0.45至0.85,或0.45至0.8,或0.45至0.75,或0.45至0.7,或0.45至0.65,或0.5至0.95,或0.5至0.9,或0.5至0.85,或0.5至0.8,或0.5至0.75,或0.5至0.7,或0.5至0.65,或0.1至0.9,或0.1至0.85,或0.1至0.8。 In one embodiment or any other embodiment, category or subcategory combination with this first aspect, wherein DS Pr is 0.1 to 0.9, or 0.1 to 0.85, or 0.1 to 0.8, or 0.1 to 0.75, or 0.1 to 0.7, or 0.1 to 0.6, or 0.1 to 0.5, or 0.1 to 0.4, or 0.15 to 0.95, or 0.15 to 0.9, or 0.15 to 0.85, or 0.15 to 0.8, or 0.15 to 0.75, or 0.15 to 0.7, or 0.15 to 0.65 , or 0.2 to 0.95, or 0.2 to 0.9, or 0.2 to 0.85, or 0.2 to 0.8, or 0.2 to 0.75, or 0.2 to 0.7, or 0.2 to 0.65, 0.25 to 0.95, or 0.25 to 0.9, or 0.25 to 0.85, or 0.25 to 0.8, or 0.25 to 0.75, or 0.25 to 0.7, or 0.25 to 0.65, or 0.3 to 0.95, or 0.3 to 0.9, or 0.3 to 0.85, or 0.3 to 0.8, or 0.3 to 0.75, or 0.3 to 0.7, Or 0.3 to 0.65, or 0.35 to 0.95, or 0.35 to 0.9, or 0.35 to 0.85, or 0.35 to 0.8, or 0.35 to 0.75, or 0.35 to 0.7, or 0.35 to 0.65, or 0.4 to 0.95, or 0.4 to 0.9, or 0.4 to 0.85, or 0.4 to 0.8, or 0.4 to 0.75, or 0.4 to 0.7, or 0.4 to 0.65, or 0.45 to 0.95, or 0.45 to 0.9, or 0.45 to 0.85, or 0.45 to 0.8, or 0.45 to 0.75, or 0.45 to 0.7, or 0.45 to 0.65, or 0.5 to 0.95, or 0.5 to 0.9, or 0.5 to 0.85, or 0.5 to 0.8, or 0.5 to 0.75, or 0.5 to 0.7, or 0.5 to 0.65, or 0.1 to 0.9, Or 0.1 to 0.85, or 0.1 to 0.8.
在一個實施例中或與此第一態樣之任何其他實施例、類別或子類別組合,其中DS OH為0.5至1.5,或0.5至1.45,或0.5至1.40,或0.5至1.35,或0.5至1.30,或0.5至1.25,或0.5至1.2,或0.5至1.15,或0.5至1.1,或0.5至1.05,或0.5至1.0,或0.5至0.95或0.5至0.9,或0.55至1.5,或0.55至1.45,或0.55至1.40,或0.55至1.35,或0.55至1.30,或0.55至1.25,或0.55至1.2,或0.55至1.15,或0.55至1.1,或0.55至1.05,或0.55至1.0,或0.55至0.95或0.55至0.9,或0.6至1.5,或0.6至1.45,或0.6至1.40,或0.6至1.35,或0.6至1.30,或0.6至1.25,或0.6至1.2,或0.6至1.15,或0.6至1.1,或0.6至1.05,或0.6至1.0,或0.6至0.95或0.6至0.9,或0.65至1.5,或0.65至1.45,或0.65至1.40,或0.65至1.35,或0.65至1.30,或0.65至1.25,或0.65至1.2,或0.65至1.15,或0.65至1.1,或0.65至1.05,或0.65至1.0,或0.65至0.95或0.65至0.9,或0.7至1.5,或0.7至1.45,或0.7至1.40,或0.7至1.35,或0.7至1.30,或0.7至1.25,或0.7至1.2,或0.7至1.15,或0.7至1.1,或0.7至1.05,或0.7至1.0,或0.7至0.95或0.7至0.9。 In one embodiment or any other embodiment, category or subcategory combination with this first aspect, wherein DS OH is 0.5 to 1.5, or 0.5 to 1.45, or 0.5 to 1.40, or 0.5 to 1.35, or 0.5 to 1.30, or 0.5 to 1.25, or 0.5 to 1.2, or 0.5 to 1.15, or 0.5 to 1.1, or 0.5 to 1.05, or 0.5 to 1.0, or 0.5 to 0.95, or 0.5 to 0.9, or 0.55 to 1.5, or 0.55 to 1.45 , or 0.55 to 1.40, or 0.55 to 1.35, or 0.55 to 1.30, or 0.55 to 1.25, or 0.55 to 1.2, or 0.55 to 1.15, or 0.55 to 1.1, or 0.55 to 1.05, or 0.55 to 1.0, or 0.55 to 0.95 Or 0.55 to 0.9, or 0.6 to 1.5, or 0.6 to 1.45, or 0.6 to 1.40, or 0.6 to 1.35, or 0.6 to 1.30, or 0.6 to 1.25, or 0.6 to 1.2, or 0.6 to 1.15, or 0.6 to 1.1, Or 0.6 to 1.05, or 0.6 to 1.0, or 0.6 to 0.95, or 0.6 to 0.9, or 0.65 to 1.5, or 0.65 to 1.45, or 0.65 to 1.40, or 0.65 to 1.35, or 0.65 to 1.30, or 0.65 to 1.25, or 0.65 to 1.2, or 0.65 to 1.15, or 0.65 to 1.1, or 0.65 to 1.05, or 0.65 to 1.0, or 0.65 to 0.95, or 0.65 to 0.9, or 0.7 to 1.5, or 0.7 to 1.45, or 0.7 to 1.40, or 0.7 to 1.35, or 0.7 to 1.30, or 0.7 to 1.25, or 0.7 to 1.2, or 0.7 to 1.15, or 0.7 to 1.1, or 0.7 to 1.05, or 0.7 to 1.0, or 0.7 to 0.95, or 0.7 to 0.9.
在一個實施例中或與此第一態樣之任何其他實施例、類別或子類別組合,其中DS Pr與DS Ac之和為1.9至2.44,或1.9至2.0,或1.9至2.1,或1.9至2.2,或1.9至2.3,或2.0至2.44,或2.0至2.1,或2.0至2.2,或2.0至2.3,或2.1至2.44,或2.1至2.2,或2.1至2.3,或2.2至2.44,或2.2至2.3。 In one embodiment or any other embodiment, category or subcategory combination with this first aspect, wherein the sum of DS Pr and DS Ac is 1.9 to 2.44, or 1.9 to 2.0, or 1.9 to 2.1, or 1.9 to 2.2, or 1.9 to 2.3, or 2.0 to 2.44, or 2.0 to 2.1, or 2.0 to 2.2, or 2.0 to 2.3, or 2.1 to 2.44, or 2.1 to 2.2, or 2.1 to 2.3, or 2.2 to 2.44, or 2.2 to 2.3.
在一個實施例中或與此第一態樣之任何其他實施例、類別或子類別組合,其中根據OECD 301F測試方法,MCE在56天時展現至少40%可生物降解性,至少45%可生物降解性,或至少50%可生物降解性,或至少55%可生物降解性,至少60%可生物降解性,或至少65%可生物降解性,或至少70%可生物降解性,或至少75%可生物降解性,或至少80%可生物降解性,或至少85%可生物降解性。In one embodiment or any other embodiment, category or subcategory combination with this first aspect, wherein the MCE exhibits at least 40% biodegradability and at least 45% biodegradability at 56 days according to OECD 301F test method Degradable, or at least 50% biodegradable, or at least 55% biodegradable, at least 60% biodegradable, or at least 65% biodegradable, or at least 70% biodegradable, or at least 75 % biodegradable, or at least 80% biodegradable, or at least 85% biodegradable.
在一個實施例中或與此第一態樣之任何其他實施例、類別或子類別組合,MCE具有在以下範圍內之重量平均分子量:5,000至100,000 Da,或5,000至50,000 Da,或5,000至25,000 Da,或15,000至100,000 Da,或15,000至50,000 Da,或15,000至25,000 Da,或50,000至100,000 Da,或75,000至100,000 Da,或15,000至250,000 Da。In one embodiment, or any other embodiment, class, or subclass combination with this first aspect, the MCE has a weight average molecular weight in the following range: 5,000 to 100,000 Da, or 5,000 to 50,000 Da, or 5,000 to 25,000 Da, or 15,000 to 100,000 Da, or 15,000 to 50,000 Da, or 15,000 to 25,000 Da, or 50,000 to 100,000 Da, or 75,000 to 100,000 Da, or 15,000 to 250,000 Da.
在第二態樣中,本申請案揭示一種混合纖維素酯(「MCE」),其包含:(1)複數個乙醯基取代基;(2)複數個丙醯基取代基;及(3)複數個羥基取代基,其中:MCE對於乙醯基取代基的平均取代度(「DS Ac」)為0.6至1.2,MCE對於丙醯基取代基的平均取代度(「DS Pr」)為1.05至1.4,且MCE對於羥基取代基的平均取代度(「DS OH」)為0.7至1.4。 In a second aspect, the present application discloses a mixed cellulose ester ("MCE") comprising: (1) a plurality of acetyl substituents; (2) a plurality of propyl substituents; and (3) ) a plurality of hydroxyl substituents, wherein: the average degree of substitution of MCE for the acetyl substituent ("DS Ac ") is 0.6 to 1.2, and the average degree of substitution of MCE for the propyl substituent ("DS Pr ") is 1.05 to 1.4, and the average degree of substitution of MCE for hydroxyl substituents ("DS OH ") is 0.7 to 1.4.
在一個實施例中或與此第二態樣之任何其他實施例、類別或子類別組合,其中DS Ac為0.6至0.7,或0.6至0.8,或0.6至0.9,或0.6至1.0,或0.6至1.1,或0.7至0.9,或0.7至1.0,或0.7至1.1,或0.7至1.2,或0.8至0.9,或0.8至1.0,或0.8至1.1,或0.8至1.2,或0.9至1.0,或0.9至1.1,或0.9至1.2,或1.0至1.1,或1.0至1.2,或1.1至1.2。 In one embodiment or any other embodiment, category or subcategory combination with this second aspect, wherein DS Ac is 0.6 to 0.7, or 0.6 to 0.8, or 0.6 to 0.9, or 0.6 to 1.0, or 0.6 to 1.1, or 0.7 to 0.9, or 0.7 to 1.0, or 0.7 to 1.1, or 0.7 to 1.2, or 0.8 to 0.9, or 0.8 to 1.0, or 0.8 to 1.1, or 0.8 to 1.2, or 0.9 to 1.0, or 0.9 to 1.1, or 0.9 to 1.2, or 1.0 to 1.1, or 1.0 to 1.2, or 1.1 to 1.2.
在一個實施例中或與此第二態樣之任何其他實施例、類別或子類別組合,其中DS Pr為1.05至1.35,或1.05至1.3,或1.05至1.25,或1.05至1.2,或1.05至1.15,或1.05至1.1,或1.1至1.4,或1.1至1.35,或1.1至1.3,或1.1至1.25,或1.1至1.2,或1.1至1.15,或1.15至1.4,或1.15至1.35,或1.15至1.3,或1.15至1.25,或1.15至1.2,或1.2至1.4,或1.2至1.35,或1.2至1.3,或1.2至1.25,或1.25至1.4,或1.25至1.35,或1.25至1.3,或1.3至1.4,或1.3至1.35。 In one embodiment or any other embodiment, category or subcategory combination with this second aspect, wherein DS Pr is from 1.05 to 1.35, or from 1.05 to 1.3, or from 1.05 to 1.25, or from 1.05 to 1.2, or from 1.05 to 1.15, or 1.05 to 1.1, or 1.1 to 1.4, or 1.1 to 1.35, or 1.1 to 1.3, or 1.1 to 1.25, or 1.1 to 1.2, or 1.1 to 1.15, or 1.15 to 1.4, or 1.15 to 1.35, or 1.15 to 1.3, or 1.15 to 1.25, or 1.15 to 1.2, or 1.2 to 1.4, or 1.2 to 1.35, or 1.2 to 1.3, or 1.2 to 1.25, or 1.25 to 1.4, or 1.25 to 1.35, or 1.25 to 1.3, or 1.3 to 1.4, or 1.3 to 1.35.
在一個實施例中或與此第二態樣之任何其他實施例、類別或子類別組合,其中DS OH為0.7至1.35,或0.7至1.3,或0.7至1.25,或0.7至1.2,或0.7至1.15,或0.7至1.1,或0.7至1.05,或0.7至1.0,或0.7至0.95,或0.7至0.9,或0.7至0.85,或0.7至0.8,或0.7至0.75,或0.75至1.4,或0.75至1.35,或0.75至1.3,或0.75至1.25,或0.75至1.2,或0.75至1.15,或0.75至1.1,或0.75至1.05,或0.75至1.0,或0.75至0.95,或0.8至1.4,或0.8至1.35,或0.8至1.3,或0.8至1.25,或0.8至1.2,或0.8至1.15,或0.8至1.1,或0.8至1.05,或0.85至1.4,或0.85至1.35,或0.85至1.3,或0.85至1.25,或0.85至1.2,或0.85至1.15,或0.85至1.1,或0.85至1.05,或0.9至1.4,或0.9至1.35,或0.9至1.3,或0.9至1.25,或0.9至1.2,或0.9至1.15,或0.9至1.1,或0.9至1.05。 In one embodiment or any other embodiment, category or subcategory combination with this second aspect, wherein DS OH is 0.7 to 1.35, or 0.7 to 1.3, or 0.7 to 1.25, or 0.7 to 1.2, or 0.7 to 1.15, or 0.7 to 1.1, or 0.7 to 1.05, or 0.7 to 1.0, or 0.7 to 0.95, or 0.7 to 0.9, or 0.7 to 0.85, or 0.7 to 0.8, or 0.7 to 0.75, or 0.75 to 1.4, or 0.75 to 1.35, or 0.75 to 1.3, or 0.75 to 1.25, or 0.75 to 1.2, or 0.75 to 1.15, or 0.75 to 1.1, or 0.75 to 1.05, or 0.75 to 1.0, or 0.75 to 0.95, or 0.8 to 1.4, or 0.8 to 1.35, or 0.8 to 1.3, or 0.8 to 1.25, or 0.8 to 1.2, or 0.8 to 1.15, or 0.8 to 1.1, or 0.8 to 1.05, or 0.85 to 1.4, or 0.85 to 1.35, or 0.85 to 1.3, or 0.85 to 1.25, or 0.85 to 1.2, or 0.85 to 1.15, or 0.85 to 1.1, or 0.85 to 1.05, or 0.9 to 1.4, or 0.9 to 1.35, or 0.9 to 1.3, or 0.9 to 1.25, or 0.9 to 1.2, or 0.9 to 1.15, or 0.9 to 1.1, or 0.9 to 1.05.
在一個實施例中或與此第二態樣之任何其他實施例、類別或子類別組合,其中DS Pr與DS Ac之和為1.65至2.3,或1.65至2.2,或1.65至2.1,或1.65至2.0,或1.65至1.9,或1.65至1.8,或1.7至2.3,或1.7至2.2,或1.7至2.1,或1.7至2.0,或1.7至1.9,或1.7至1.8,或1.75至2.3,或1.75至2.2,或1.75至2.1,或1.75至2.0,或1.75至1.9,或1.8至2.3,或1.8至2.2,或1.8至2.1,或1.8至2.0,或1.8至1.9,或1.9至2.3,或1.9至2.2,或1.9至2.1,或1.9至2.0,或2.0至2.3,或2.0至2.2,或2.0至2.1。 In one embodiment or any other embodiment, category or subcategory combination with this second aspect, wherein the sum of DS Pr and DS Ac is 1.65 to 2.3, or 1.65 to 2.2, or 1.65 to 2.1, or 1.65 to 2.0, or 1.65 to 1.9, or 1.65 to 1.8, or 1.7 to 2.3, or 1.7 to 2.2, or 1.7 to 2.1, or 1.7 to 2.0, or 1.7 to 1.9, or 1.7 to 1.8, or 1.75 to 2.3, or 1.75 to 2.2, or 1.75 to 2.1, or 1.75 to 2.0, or 1.75 to 1.9, or 1.8 to 2.3, or 1.8 to 2.2, or 1.8 to 2.1, or 1.8 to 2.0, or 1.8 to 1.9, or 1.9 to 2.3, or 1.9 to 2.2, or 1.9 to 2.1, or 1.9 to 2.0, or 2.0 to 2.3, or 2.0 to 2.2, or 2.0 to 2.1.
在一個實施例中或與此第二態樣之任何其他實施例、類別或子類別組合,其中DS OH為0.6至0.7,或0.7至1.35,或0.7至1.3,或0.7至1.25,或0.7至1.2,或0.7至1.15,或0.7至1.1,或0.7至1.05,或0.7至1.0,或0.7至0.95,或0.7至0.9,或0.7至0.85,或0.7至0.8,或0.7至0.75,或0.75至1.4,或0.75至1.35,或0.75至1.3,或0.75至1.25,或0.75至1.2,或0.75至1.15,或0.75至1.1,或0.75至1.05,或0.75至1.0,或0.75至0.95,或0.8至1.4,或0.8至1.35,或0.8至1.3,或0.8至1.25,或0.8至1.2,或0.8至1.15,或0.8至1.1,或0.8至1.05,或0.85至1.4,或0.85至1.35,或0.85至1.3,或0.85至1.25,或0.85至1.2,或0.85至1.15,或0.85至1.1,或0.85至1.05,或0.9至1.4,或0.9至1.35,或0.9至1.3,或0.9至1.25,或0.9至1.2,或0.9至1.15,或0.9至1.1,或0.9至1.05。 In one embodiment or any other embodiment, category or subcategory combination with this second aspect, wherein DS OH is 0.6 to 0.7, or 0.7 to 1.35, or 0.7 to 1.3, or 0.7 to 1.25, or 0.7 to 1.2, or 0.7 to 1.15, or 0.7 to 1.1, or 0.7 to 1.05, or 0.7 to 1.0, or 0.7 to 0.95, or 0.7 to 0.9, or 0.7 to 0.85, or 0.7 to 0.8, or 0.7 to 0.75, or 0.75 to 1.4, or 0.75 to 1.35, or 0.75 to 1.3, or 0.75 to 1.25, or 0.75 to 1.2, or 0.75 to 1.15, or 0.75 to 1.1, or 0.75 to 1.05, or 0.75 to 1.0, or 0.75 to 0.95, or 0.8 to 1.4, or 0.8 to 1.35, or 0.8 to 1.3, or 0.8 to 1.25, or 0.8 to 1.2, or 0.8 to 1.15, or 0.8 to 1.1, or 0.8 to 1.05, or 0.85 to 1.4, or 0.85 to 1.35, or 0.85 to 1.3, or 0.85 to 1.25, or 0.85 to 1.2, or 0.85 to 1.15, or 0.85 to 1.1, or 0.85 to 1.05, or 0.9 to 1.4, or 0.9 to 1.35, or 0.9 to 1.3, or 0.9 to 1.25, or 0.9 to 1.2, or 0.9 to 1.15, or 0.9 to 1.1, or 0.9 to 1.05.
在一個實施例中或與此第二態樣之任何其他實施例、類別或子類別組合,其中根據OECD 301F測試方法,MCE在56天時展現至少40%可生物降解性,至少45%可生物降解性,或至少50%可生物降解性,或至少55%可生物降解性,至少60%可生物降解性,或至少65%可生物降解性,或至少70%可生物降解性,或至少75%可生物降解性,或至少80%可生物降解性,或至少85%可生物降解性。In one embodiment or any other embodiment, category or subcategory combination with this second aspect, wherein the MCE exhibits at least 40% biodegradability and at least 45% biodegradability at 56 days according to OECD 301F test method Degradable, or at least 50% biodegradable, or at least 55% biodegradable, at least 60% biodegradable, or at least 65% biodegradable, or at least 70% biodegradable, or at least 75 % biodegradable, or at least 80% biodegradable, or at least 85% biodegradable.
在一個實施例中或與此第二態樣之任何其他實施例、類別或子類別組合,MCE具有在以下範圍內之重量平均分子量:5,000至100,000 Da,或5,000至50,000 Da,或5,000至25,000 Da,或15,000至100,000 Da,或15,000至50,000 Da,或15,000至25,000 Da,或50,000至100,000 Da,或75,000至100,000 Da,或15,000至250,000 Da。In one embodiment or any other embodiment, category or subcategory combination with this second aspect, the MCE has a weight average molecular weight in the following range: 5,000 to 100,000 Da, or 5,000 to 50,000 Da, or 5,000 to 25,000 Da, or 15,000 to 100,000 Da, or 15,000 to 50,000 Da, or 15,000 to 25,000 Da, or 50,000 to 100,000 Da, or 75,000 to 100,000 Da, or 15,000 to 250,000 Da.
在第三態樣中,本申請案亦揭示一種混合纖維素酯(「MCE」),其包含:(1)複數個乙醯基取代基;(2)複數個丁醯基取代基;及(3)複數個羥基取代基,其中:MCE對於乙醯基取代基的平均取代度(「DS Ac」)為0.9至2.4,MCE對於丁醯基取代基的平均取代度(「DS Bu」)為0.1至1.1,MCE對於羥基取代基的平均取代度(「DS OH」)為0.6至1.5。 In a third aspect, the present application also discloses a mixed cellulose ester ("MCE") comprising: (1) a plurality of acetyl substituents; (2) a plurality of butyl substituents; and (3) A plurality of hydroxyl substituents, wherein: the average degree of substitution of MCE for the acetyl substituent ("DS Ac ") is 0.9 to 2.4, and the average degree of substitution of MCE for the butyl substituent ("DS Bu ") is 0.1 to 1.1, The average degree of substitution of MCE for hydroxyl substituents ("DS OH ") is 0.6 to 1.5.
在一個實施例中或與此第三態樣之任何其他實施例、類別或子類別組合,其中DS Ac為0.9至2.4,0.9至2.3,或0.9至2.2,或0.9至2.1,或0.9至2.0,或0.9至1.9,或0.9至1.8,或0.9至1.7,或0.9至1.6,或0.9至1.4,0.9至1.3,或0.9至1.2,或0.9至1.1,或0.9至1.0,或0.92至2.4,0.92至2.3,或0.92至2.2,或0.92至2.1,或0.92至2.0,或0.92至1.9,或0.92至1.8,或0.92至1.7,或0.92至1.6,或0.92至1.4,0.92至1.3,或0.92至1.2,或0.92至1.1,或0.92至1.0,或0.94至2.4,0.94至2.3,或0.94至2.2,或0.94至2.1,或0.94至2.0,或0.94至1.9,或0.94至1.8,或0.94至1.7,或0.94至1.6,或0.94至1.4,0.94至1.3,或0.94至1.2,或0.94至1.1,或0.94至1.0,或0.96至2.4,0.96至2.3,或0.96至2.2,或0.96至2.1,或0.96至2.0,或0.96至1.9,或0.96至1.8,或0.96至1.7,或0.96至1.6,或0.96至1.4,0.96至1.3,或0.96至1.2,或0.96至1.1,或0.96至1.0,或0.98至2.4,0.98至2.3,或0.98至2.2,或0.98至2.1,或0.98至2.0,或0.98至1.9,或0.98至1.8,或0.98至1.7,或0.98至1.6,0.98至1.4,0.98至1.3,或0.98至1.2,或0.98至1.1,或0.98至1.0,或1.0至2.4,1.0至2.3,或1.0至2.2,或1.0至2.1,或1.0至2.0,或1.0至1.9,或1.0至1.8,或1.0至1.7,或1.0至1.6,或1.0至1.4,或1.0至1.3,1.0至1.2,或1.0至1.1,或1.1至2.4,或1.1至2.3,或1.1至2.2,或1.1至2.1,或1.1至2.0,或1.1至1.9,或1.1至1.8,或1.1至1.7,或1.1至1.6,1.1至1.4,或1.1至1.3,或1.1至1.2,或1.2至2.4,或1.2至2.3,或1.2至2.2,或1.2至2.1,或1.2至2.0,或1.2至1.9,或1.2至1.8,或1.2至1.7,或1.2至1.6,或1.2至1.4,或1.2至1.3,或1.3至2.4,或1.3至2.3,或1.3至2.2,或1.3至2.1,或1.3至2.0,或1.3至1.9,或1.3至1.8,或1.3至1.7,或1.3至1.6,或1.3至1.4,或1.4至2.4,或1.4至2.3,或1.4至2.2,或1.4至2.1,或1.4至2.0,或1.4至1.9,或1.4至1.8,或1.4至1.7,或1.4至1.6,或1.5至2.4,或1.5至2.3,或1.5至2.2,或1.5至2.1,或1.5至2.0,或1.5至1.9,或1.5至1.8,或1.5至1.7,或1.5至1.6,或1.6至2.4,或1.6至2.3,或1.6至2.2,或1.6至2.1,或1.6至2.0,或1.6至1.9,或1.6至1.8,或1.6至1.7,或1.7至2.4,或1.7至2.3,或1.7至2.2,或1.7至2.1,或1.7至2.0,或1.7至1.9,或1.7至1.8,或1.8至2.3,或1.8至2.1,或1.8至2.0,或1.8至1.9,或1.9至2.3,或1.9至2.2,或1.9至2.1,或1.9至2.0,或2.0至2.4,或2.0至2.3,或2.0至2.2,或2.0至2.1,或2.1至2.4,或2.1至2.3,或2.1至2.2,或2.2至2.3。 In one embodiment or any other embodiment, category or subcategory combination with this third aspect, wherein DS Ac is 0.9 to 2.4, 0.9 to 2.3, or 0.9 to 2.2, or 0.9 to 2.1, or 0.9 to 2.0 , or 0.9 to 1.9, or 0.9 to 1.8, or 0.9 to 1.7, or 0.9 to 1.6, or 0.9 to 1.4, 0.9 to 1.3, or 0.9 to 1.2, or 0.9 to 1.1, or 0.9 to 1.0, or 0.92 to 2.4, 0.92 to 2.3, or 0.92 to 2.2, or 0.92 to 2.1, or 0.92 to 2.0, or 0.92 to 1.9, or 0.92 to 1.8, or 0.92 to 1.7, or 0.92 to 1.6, or 0.92 to 1.4, 0.92 to 1.3, or 0.92 to 1.2, or 0.92 to 1.1, or 0.92 to 1.0, or 0.94 to 2.4, 0.94 to 2.3, or 0.94 to 2.2, or 0.94 to 2.1, or 0.94 to 2.0, or 0.94 to 1.9, or 0.94 to 1.8, or 0.94 to 1.7, or 0.94 to 1.6, or 0.94 to 1.4, 0.94 to 1.3, or 0.94 to 1.2, or 0.94 to 1.1, or 0.94 to 1.0, or 0.96 to 2.4, 0.96 to 2.3, or 0.96 to 2.2, or 0.96 to 2.1, Or 0.96 to 2.0, or 0.96 to 1.9, or 0.96 to 1.8, or 0.96 to 1.7, or 0.96 to 1.6, or 0.96 to 1.4, 0.96 to 1.3, or 0.96 to 1.2, or 0.96 to 1.1, or 0.96 to 1.0, or 0.98 to 2.4, 0.98 to 2.3, or 0.98 to 2.2, or 0.98 to 2.1, or 0.98 to 2.0, or 0.98 to 1.9, or 0.98 to 1.8, or 0.98 to 1.7, or 0.98 to 1.6, 0.98 to 1.4, 0.98 to 1.3 , or 0.98 to 1.2, or 0.98 to 1.1, or 0.98 to 1.0, or 1.0 to 2.4, 1.0 to 2.3, or 1.0 to 2.2, or 1.0 to 2.1, or 1.0 to 2.0, or 1.0 to 1.9, or 1.0 to 1.8, or 1.0 to 1.7, or 1.0 to 1.6, or 1.0 to 1.4, or 1.0 to 1.3, 1.0 to 1.2, or 1.0 to 1.1, or 1.1 to 2.4, or 1.1 to 2.3, or 1.1 to 2.2, or 1.1 to 2.1, or 1.1 to 2.0, or 1.1 to 1.9, or 1.1 to 1.8, or 1.1 to 1.7, or 1.1 to 1.6, 1.1 to 1.4, or 1.1 to 1.3, or 1.1 to 1.2, or 1.2 to 2.4, or 1.2 to 2.3, or 1.2 to 2.2, or 1.2 to 2.1, or 1.2 to 2.0, or 1.2 to 1.9, or 1.2 to 1.8, or 1.2 to 1.7, or 1.2 to 1.6, or 1.2 to 1.4, or 1.2 to 1.3, or 1.3 to 2.4, or 1.3 to 2.3, or 1.3 to 2.2, or 1.3 to 2.1, or 1.3 to 2.0, or 1.3 to 1.9, or 1.3 to 1.8, or 1.3 to 1.7, or 1.3 to 1.6, or 1.3 to 1.4, or 1.4 to 2.4, or 1.4 to 2.3, or 1.4 to 2.2, or 1.4 to 2.1, or 1.4 to 2.0, or 1.4 to 1.9, or 1.4 to 1.8, or 1.4 to 1.7, or 1.4 to 1.6, or 1.5 to 2.4, or 1.5 to 2.3, or 1.5 to 2.2, or 1.5 to 2.1, or 1.5 to 2.0, or 1.5 to 1.9, or 1.5 to 1.8, or 1.5 to 1.7, or 1.5 to 1.6, or 1.6 to 2.4, or 1.6 to 2.3, or 1.6 to 2.2, or 1.6 to 2.1, or 1.6 to 2.0, or 1.6 to 1.9, or 1.6 to 1.8, or 1.6 to 1.7, or 1.7 to 2.4, or 1.7 to 2.3, or 1.7 to 2.2, or 1.7 to 2.1, or 1.7 to 2.0, or 1.7 to 1.9, or 1.7 to 1.8, or 1.8 to 2.3, or 1.8 to 2.1, or 1.8 to 2.0, or 1.8 to 1.9, or 1.9 to 2.3, or 1.9 to 2.2, or 1.9 to 2.1, or 1.9 to 2.0, or 2.0 to 2.4, or 2.0 to 2.3, or 2.0 to 2.2, or 2.0 to 2.1, or 2.1 to 2.4, or 2.1 to 2.3, or 2.1 to 2.2, or 2.2 to 2.3.
在一個實施例中或與此第三態樣之任何其他實施例、類別或子類別組合,其中DS Bu為0.1至1.35,或0.1至1.3,或0.1至1.25,或0.1至1.2,或0.1至1.15,或0.1至1.1,或0.1至1.0,或0.1至0.8,或0.1至0.6,或0.2至1.35,或0.2至1.3,或0.2至1.25,或0.2至1.2,或0.2至1.15,或0.2至1.1,或0.2至1.0,或0.2至0.8,或0.2至0.6,或0.2至0.4,或0.3至1.35,或0.3至1.3,或0.3至1.25,或0.3至1.2,或0.3至1.15,或0.3至1.1,或0.3至1.0,或0.3至0.8,或0.3至0.6,或0.3至0.5,或0.4至1.35,或0.4至1.3,或0.4至1.25,或0.4至1.2,或0.4至1.15,或0.4至1.1,或0.4至1.0,或0.4至0.8,或0.4至0.6,或0.5至1.35,或0.5至1.3,或0.5至1.25,或0.5至1.2,或0.5至1.15,或0.5至1.1,或0.5至1.0,或0.5至0.8,或0.5至0.7,或0.6至1.35,或0.6至1.3,或0.6至1.25,或0.6至1.2,或0.6至1.15,或0.6至1.1,或0.6至1.0,或0.6至0.8,或0.7至1.35,或0.7至1.3,或0.7至1.25,或0.7至1.2,或0.7至1.15,或0.7至1.1,或0.7至1.0,或0.8至1.35,或0.8至1.3,或0.8至1.25,或0.8至1.2,或0.8至1.15,或0.8至1.1,或0.8至1.0,或0.9至1.35,或0.9至1.3,或0.9至1.25,或0.9至1.2,或0.9至1.15,或0.9至1.1,或1.0至1.35,或1.0至1.3,或1.0至1.25,或1.0至1.2,或1.0至1.15,或1.0至1.1,或1.05至1.35,或1.05至1.3,或1.05至1.25,或1.05至1.2,或1.05至1.15,或1.05至1.1,或1.1至1.4,或1.1至1.35,或1.1至1.3,或1.1至1.25,或1.1至1.2,或1.1至1.15,或1.15至1.4,或1.15至1.35,或1.15至1.3,或1.15至1.25,或1.15至1.2,或1.2至1.4,或1.2至1.35,或1.2至1.3,或1.2至1.25,或1.25至1.4,或1.25至1.35,或1.25至1.3,或1.3至1.4,或1.3至1.35。 In one embodiment or any other embodiment, category or subcategory combination with this third aspect, wherein DS Bu is 0.1 to 1.35, or 0.1 to 1.3, or 0.1 to 1.25, or 0.1 to 1.2, or 0.1 to 1.15, or 0.1 to 1.1, or 0.1 to 1.0, or 0.1 to 0.8, or 0.1 to 0.6, or 0.2 to 1.35, or 0.2 to 1.3, or 0.2 to 1.25, or 0.2 to 1.2, or 0.2 to 1.15, or 0.2 to 1.1, or 0.2 to 1.0, or 0.2 to 0.8, or 0.2 to 0.6, or 0.2 to 0.4, or 0.3 to 1.35, or 0.3 to 1.3, or 0.3 to 1.25, or 0.3 to 1.2, or 0.3 to 1.15, or 0.3 to 1.1, or 0.3 to 1.0, or 0.3 to 0.8, or 0.3 to 0.6, or 0.3 to 0.5, or 0.4 to 1.35, or 0.4 to 1.3, or 0.4 to 1.25, or 0.4 to 1.2, or 0.4 to 1.15, or 0.4 to 1.1, or 0.4 to 1.0, or 0.4 to 0.8, or 0.4 to 0.6, or 0.5 to 1.35, or 0.5 to 1.3, or 0.5 to 1.25, or 0.5 to 1.2, or 0.5 to 1.15, or 0.5 to 1.1, or 0.5 to 1.0, or 0.5 to 0.8, or 0.5 to 0.7, or 0.6 to 1.35, or 0.6 to 1.3, or 0.6 to 1.25, or 0.6 to 1.2, or 0.6 to 1.15, or 0.6 to 1.1, or 0.6 to 1.0, or 0.6 to 0.8, or 0.7 to 1.35, or 0.7 to 1.3, or 0.7 to 1.25, or 0.7 to 1.2, or 0.7 to 1.15, or 0.7 to 1.1, or 0.7 to 1.0, or 0.8 to 1.35, or 0.8 to 1.3, or 0.8 to 1.25, or 0.8 to 1.2, or 0.8 to 1.15, or 0.8 to 1.1, or 0.8 to 1.0, or 0.9 to 1.35, or 0.9 to 1.3, or 0.9 to 1.25, or 0.9 to 1.2, or 0.9 to 1.15, or 0.9 to 1.1, or 1.0 to 1.35, or 1.0 to 1.3, or 1.0 to 1.25, or 1.0 to 1.2, or 1.0 to 1.15, or 1.0 to 1.1, or 1.05 to 1.35, or 1.05 to 1.3, or 1.05 to 1.25, or 1.05 to 1.2, or 1.05 to 1.15, or 1.05 to 1.1, or 1.1 to 1.4, or 1.1 to 1.35, or 1.1 to 1.3, or 1.1 to 1.25, or 1.1 to 1.2, or 1.1 to 1.15, or 1.15 to 1.4, or 1.15 to 1.35, or 1.15 to 1.3, or 1.15 to 1.25, or 1.15 to 1.2, or 1.2 to 1.4, or 1.2 to 1.35, or 1.2 to 1.3, or 1.2 to 1.25, or 1.25 to 1.4, or 1.25 to 1.35, or 1.25 to 1.3, or 1.3 to 1.4, or 1.3 to 1.35.
在一個實施例中或與此第三態樣之任何其他實施例、類別或子類別組合,其中DS OH為0.5至1.0,或0.5至0.95,或0.5至0.9,或0.5至0.85,或0.5至0.8,或0.5至0.75,或0.5至0.7,或0.5至0.65,或0.5至0.6,或0.5至0.55,或0.55至1.0,或0.55至0.95,或0.55至0.9,或0.55至0.85,或0.55至0.8,或0.55至0.75,或0.55至0.7,或0.55或0.65,或0.55至0.6,或0.6至0.65,或0.6至0.7,或0.6至0.75,或0.6至0.8,或0.6至0.85,或0.6至0.9,或0.6至0.95,或0.6至1.0,或0.65至0.7,或0.65至0.75,或0.65至0.8,或0.65至0.85,或0.65至0.9,或0.65至0.95,或0.65至1.0。 In one embodiment or any other embodiment, category or subcategory combination with this third aspect, wherein DS OH is 0.5 to 1.0, or 0.5 to 0.95, or 0.5 to 0.9, or 0.5 to 0.85, or 0.5 to 0.8, or 0.5 to 0.75, or 0.5 to 0.7, or 0.5 to 0.65, or 0.5 to 0.6, or 0.5 to 0.55, or 0.55 to 1.0, or 0.55 to 0.95, or 0.55 to 0.9, or 0.55 to 0.85, or 0.55 to 0.8, or 0.55 to 0.75, or 0.55 to 0.7, or 0.55 or 0.65, or 0.55 to 0.6, or 0.6 to 0.65, or 0.6 to 0.7, or 0.6 to 0.75, or 0.6 to 0.8, or 0.6 to 0.85, or 0.6 to 0.9, or 0.6 to 0.95, or 0.6 to 1.0, or 0.65 to 0.7, or 0.65 to 0.75, or 0.65 to 0.8, or 0.65 to 0.85, or 0.65 to 0.9, or 0.65 to 0.95, or 0.65 to 1.0.
在一個實施例中或與此第三態樣之任何其他實施例、類別或子類別組合,其中DS Bu與DS Ac之和為1.65至2.3,或1.65至2.2,或1.65至2.1,或1.65至2.0,或1.65至1.9,或1.65至1.8,或1.7至2.3,或1.7至2.2,或1.7至2.1,或1.7至2.0,或1.7至1.9,或1.7至1.8,或1.75至2.3,或1.75至2.2,或1.75至2.1,或1.75至2.0,或1.75至1.9,或1.8至2.3,或1.8至2.2,或1.8至2.1,或1.8至2.0,或1.8至1.9,或1.9至2.3,或1.9至2.2,或1.9至2.1,或1.9至2.0,2.0至2.4,或2.0至2.3,或2.0至2.2,或2.0至2.1。 In one embodiment or any other embodiment, category or subcategory combination of this third aspect, wherein the sum of DS Bu and DS Ac is 1.65 to 2.3, or 1.65 to 2.2, or 1.65 to 2.1, or 1.65 to 2.0, or 1.65 to 1.9, or 1.65 to 1.8, or 1.7 to 2.3, or 1.7 to 2.2, or 1.7 to 2.1, or 1.7 to 2.0, or 1.7 to 1.9, or 1.7 to 1.8, or 1.75 to 2.3, or 1.75 to 2.2, or 1.75 to 2.1, or 1.75 to 2.0, or 1.75 to 1.9, or 1.8 to 2.3, or 1.8 to 2.2, or 1.8 to 2.1, or 1.8 to 2.0, or 1.8 to 1.9, or 1.9 to 2.3, or 1.9 to 2.2, or 1.9 to 2.1, or 1.9 to 2.0, 2.0 to 2.4, or 2.0 to 2.3, or 2.0 to 2.2, or 2.0 to 2.1.
在一個實施例中或與此第三態樣之任何其他實施例、類別或子類別組合,其中根據OECD 301F測試方法,MCE在56天時展現至少40%可生物降解性,至少45%可生物降解性,或至少50%可生物降解性,或至少55%可生物降解性,至少60%可生物降解性,或至少65%可生物降解性,或至少70%可生物降解性,或至少75%可生物降解性,或至少80%可生物降解性,或至少85%可生物降解性。In one embodiment or any other embodiment, category or subcategory combination with this third aspect, wherein the MCE exhibits at least 40% biodegradability and at least 45% biodegradability at 56 days according to OECD 301F test method Degradable, or at least 50% biodegradable, or at least 55% biodegradable, at least 60% biodegradable, or at least 65% biodegradable, or at least 70% biodegradable, or at least 75 % biodegradable, or at least 80% biodegradable, or at least 85% biodegradable.
在一個實施例中或與此第三態樣之任何其他實施例、類別或子類別組合,MCE具有在以下範圍內之重量平均分子量:5,000至100,000 Da,或5,000至50,000 Da,或5,000至25,000 Da,或15,000至100,000 Da,或15,000至50,000 Da,或15,000至25,000 Da,或50,000至100,000 Da,或75,000至100,000 Da,或15,000至250,000 Da。In one embodiment, or any other embodiment, class, or subclass combination with this third aspect, the MCE has a weight average molecular weight in the following range: 5,000 to 100,000 Da, or 5,000 to 50,000 Da, or 5,000 to 25,000 Da, or 15,000 to 100,000 Da, or 15,000 to 50,000 Da, or 15,000 to 25,000 Da, or 50,000 to 100,000 Da, or 75,000 to 100,000 Da, or 15,000 to 250,000 Da.
在第四態樣中,本申請案亦揭示一種包含先前所揭示混合纖維素酯中之任一者的組合物。In a fourth aspect, the present application also discloses a composition comprising any of the previously disclosed mixed cellulose esters.
在一個實施例中或與此第四態樣之任何其他實施例、類別或子類別組合,其中組合物進一步包含增塑劑。增塑劑降低MCE之熔融溫度、Tg及/或熔融黏度。In one embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the composition further comprises a plasticizer. Plasticizers reduce the melting temperature, Tg and/or melt viscosity of MCE.
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,增塑劑為三乙酸甘油酯、檸檬酸三乙酯、聚(乙二醇)、Benzoflex、丙二醇、聚山梨醇酯蔗糖八乙酸酯、乙醯化檸檬酸三乙酯、乙醯檸檬酸三丁酯、Admex、三丙酸甘油酯、Scandiflex、泊洛沙姆共聚物、聚乙二醇琥珀酸酯、己二酸二異丁酯、聚乙烯吡咯啶酮及二醇三苯甲酸酯。In one category of this embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the plasticizer is triacetin, triethyl citrate, poly(ethylene glycol), Benzoflex , Propylene Glycol, Polysorbate Sucrose Octaacetate, Acetylated Triethyl Citrate, Acetylated Tributyl Citrate, Admex, Tripropionin, Scandiflex, Poloxamer Copolymer, Polyethylene Glycol Alcohol succinate, diisobutyl adipate, polyvinylpyrrolidone and glycol tribenzoate.
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之重量計,增塑劑之存在量為1至40 wt%,或1至30 wt%,或1至20 wt%,或1至10 wt%,或1至5 wt%,或5至40 wt%,或5至30 wt%,或5至20 wt%,或5至10 wt%,或5至5 wt%,或10至40 wt%,或10至30 wt%,或10至20 wt%,或10至10 wt%,或10至5 wt%,15至40 wt%,或15至30 wt%,或15至20 wt%,或15至10 wt%,或15至5 wt%。In one category of this embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the plasticizer is present in an amount of from 1 to 40 wt%, based on the weight of the cellulose ester composition, Or 1 to 30 wt%, or 1 to 20 wt%, or 1 to 10 wt%, or 1 to 5 wt%, or 5 to 40 wt%, or 5 to 30 wt%, or 5 to 20 wt%, or 5 to 10 wt%, or 5 to 5 wt%, or 10 to 40 wt%, or 10 to 30 wt%, or 10 to 20 wt%, or 10 to 10 wt%, or 10 to 5 wt%, 15 to 40 wt%, or 15 to 30 wt%, or 15 to 20 wt%, or 15 to 10 wt%, or 15 to 5 wt%.
在此實施例之一個類別中,增塑劑為可生物降解增塑劑。可生物降解增塑劑之一些實例包括三乙酸甘油酯、檸檬酸三乙酯、乙醯檸檬酸三乙酯、聚乙二醇、諸如Benzoflex™增塑劑系列之含苯甲酸酯增塑劑、諸如聚(琥珀酸丁二酯)之聚(琥珀酸烷酯)、聚醚碸、己二酸酯類增塑劑、諸如Paraplex™增塑劑系列之大豆油環氧化物、蔗糖類增塑劑、癸二酸二丁酯、甘油三丁酸酯、蔗糖乙酸異丁酸酯、Resolflex™系列增塑劑、磷酸三苯酯、羥乙酸鹽、聚(乙二醇)、2,2,4-三甲基戊烷-1,3-二基雙(2-甲基丙酸酯)及聚己內酯。In one category of this embodiment, the plasticizer is a biodegradable plasticizer. Some examples of biodegradable plasticizers include triacetin, triethyl citrate, acetyl triethyl citrate, polyethylene glycol, paraben-containing plasticizers such as the Benzoflex™ plasticizer series , such as poly(butylene succinate), poly(alkyl succinate), polyether esters, adipate plasticizers, soybean oil epoxides such as Paraplex™ plasticizer series, sucrose plasticizers Agent, dibutyl sebacate, tributyrin, sucrose acetate isobutyrate, Resolflex™ series plasticizer, triphenyl phosphate, glycolate, poly(ethylene glycol), 2,2,4 -Trimethylpentane-1,3-diylbis(2-methylpropionate) and polycaprolactone.
在一個實施例中或與此第四態樣之任何其他實施例、類別或子類別組合,組合物進一步包含與MCE不同之至少一種可生物降解聚合物。In one embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the composition further comprises at least one biodegradable polymer other than MCE.
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,可生物降解聚合物係選自聚羥基烷酸酯(PHA及PHB)、聚(乳酸) (PLA)、聚己內酯聚合物(PCL)、聚(己二酸丁二酯共-對苯二甲酸酯) (PBAT)、聚(琥珀酸乙二酯) (PES)、聚(乙酸乙烯酯) (PVA)、聚(琥珀酸丁二酯) (PBS)及共聚物[諸如聚(琥珀酸丁二酯-共-己二酸酯) (PBSA)]、其他纖維素酯、纖維素醚、澱粉、蛋白、其衍生物及其組合。In one category of this embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the biodegradable polymer is selected from the group consisting of polyhydroxyalkanoates (PHA and PHB), poly(lactic acid) (PLA), polycaprolactone polymer (PCL), poly(butylene adipate-co-terephthalate) (PBAT), poly(ethylene succinate) (PES), poly(acetic acid vinyl ester) (PVA), poly(butylene succinate) (PBS) and copolymers [such as poly(butylene succinate-co-adipate) (PBSA)], other cellulose esters, cellulose Ethers, starch, proteins, their derivatives and combinations thereof.
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,組合物包含兩種或更多種可生物降解聚合物。In one category of this embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the composition includes two or more biodegradable polymers.
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,按組合物之總重量計,組合物包含以下量的可生物降解聚合物:0.1至60 wt%,0.1至50 wt%,或0.1至40 wt%,或0.1至30 wt%,或0.1至20 wt%,或0.1至15 wt%,或0.1至10 wt%,或0.1至5 wt%,或1至40 wt%,或1至30 wt%,或1至25 wt%,或1至20 wt%,或1至10 wt%,或1至5 wt%,或5至40 wt%,或5至30 wt%,或5至25 wt%,或5至20 wt%,或5至10 wt%。In one category of this embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the composition includes the following amount of biodegradable polymer, based on the total weight of the composition: 0.1 to 60 wt%, 0.1 to 50 wt%, or 0.1 to 40 wt%, or 0.1 to 30 wt%, or 0.1 to 20 wt%, or 0.1 to 15 wt%, or 0.1 to 10 wt%, or 0.1 to 5 wt% , or 1 to 40 wt%, or 1 to 30 wt%, or 1 to 25 wt%, or 1 to 20 wt%, or 1 to 10 wt%, or 1 to 5 wt%, or 5 to 40 wt%, Or 5 to 30 wt%, or 5 to 25 wt%, or 5 to 20 wt%, or 5 to 10 wt%.
在一個實施例中或與此第四態樣之任何其他實施例、類別或子類別組合,其中組合物進一步包含填充劑、添加劑、穩定劑及/或氣味改質劑中之至少一者。In one embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the composition further includes at least one of a filler, additive, stabilizer and/or odor modifying agent.
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,填充劑屬於一種類型且以增強可生物降解性及/或可堆肥性的量存在。In one category of this embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the filler is of one type and is present in an amount that enhances biodegradability and/or compostability.
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,組合物包含選自以下之至少一種填充劑:碳水化合物(糖及鹽)、纖維素及有機填充劑(木粉、木纖維、麻纖維、碳、煤粒子、石墨及澱粉)、礦物及無機填充劑(碳酸鈣、滑石、矽石、二氧化鈦、玻璃纖維、玻璃球、氮化硼、三水合鋁、氫氧化鎂、氫氧化鈣、氧化鋁及黏土)、食物廢棄物或副產物(蛋殼、酒粕及咖啡渣)、乾燥劑(例如硫酸鈣、硫酸鎂、氧化鎂、氧化鈣)、鹼性填充劑(例如,Na 2CO 3、MgCO 3)或此等填充劑之組合(例如,混合物)。 In one category of this embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the composition includes at least one filler selected from: carbohydrates (sugar and salt), cellulose, and Organic fillers (wood powder, wood fiber, hemp fiber, carbon, coal particles, graphite and starch), mineral and inorganic fillers (calcium carbonate, talc, silica, titanium dioxide, glass fiber, glass balls, boron nitride, trioxide Hydrated aluminum, magnesium hydroxide, calcium hydroxide, alumina and clay), food waste or by-products (eggshells, wine grains and coffee grounds), desiccants (such as calcium sulfate, magnesium sulfate, magnesium oxide, calcium oxide), Alkaline fillers (eg, Na 2 CO 3 , MgCO 3 ) or combinations of these fillers (eg, mixtures).
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,組合物可包括亦充當著色劑添加劑之至少一種填充劑。在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,著色劑添加劑填充劑可選自:碳、石墨、二氧化鈦、乳白劑、染料、顏料、調色劑及其組合。In one category of this embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the composition may include at least one filler that also acts as a colorant additive. In one of the subcategories of this category or in any other embodiment, category or subcategory combination of this fourth aspect, the colorant additive filler may be selected from: carbon, graphite, titanium dioxide, opalizers, dyes, pigments, tints Colorants and combinations thereof.
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,組合物可包括亦充當穩定劑或阻燃劑之至少一種填充劑。In one category of this embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the composition may include at least one filler that also acts as a stabilizer or flame retardant.
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,均按組合物之總重量計,組合物進一步包含以下量的至少一種填充劑:1至60 wt%,或5至55 wt%,或5至50 wt%,或5至45 wt%,或5至40 wt%,或5至35 wt%,或5至30 wt%,或5至25 wt%,或10至55 wt%,或10至50 wt%,或10至45 wt%,或10至40 wt%,或10至35 wt%,或10至30 wt%,或10至25 wt%,或15至55 wt%,或15至50 wt%,或15至45 wt%,或15至40 wt%,或15至35 wt%,或15至30 wt%,或15至25 wt%,或20至55 wt%,或20至50 wt%,或20至45 wt%,或20至40 wt%,或20至35 wt%,或20至30 wt%。In one category of this embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the composition further includes at least one filler in the following amounts, based on the total weight of the composition: 1 to 60 wt%, or 5 to 55 wt%, or 5 to 50 wt%, or 5 to 45 wt%, or 5 to 40 wt%, or 5 to 35 wt%, or 5 to 30 wt%, or 5 to 25 wt%, or 10 to 55 wt%, or 10 to 50 wt%, or 10 to 45 wt%, or 10 to 40 wt%, or 10 to 35 wt%, or 10 to 30 wt%, or 10 to 25 wt %, or 15 to 55 wt%, or 15 to 50 wt%, or 15 to 45 wt%, or 15 to 40 wt%, or 15 to 35 wt%, or 15 to 30 wt%, or 15 to 25 wt% , or 20 to 55 wt%, or 20 to 50 wt%, or 20 to 45 wt%, or 20 to 40 wt%, or 20 to 35 wt%, or 20 to 30 wt%.
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,穩定劑為以下中之至少一者:UV吸收劑、抗氧化劑(例如,抗壞血酸、BHT、BHA等)、酸或自由基清除劑、環氧化油(例如,環氧化大豆油),或其組合。In one category of this embodiment or any other embodiment, category, or subcategory combination of this fourth aspect, the stabilizer is at least one of: a UV absorber, an antioxidant (eg, ascorbic acid, BHT, BHA, etc.), acids or free radical scavengers, epoxidized oils (e.g., epoxidized soybean oil), or combinations thereof.
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,穩定劑包含一或多種助抗氧化劑。In one category of this embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the stabilizer includes one or more co-antioxidants.
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,穩定劑包含選自一或多種助抗氧化劑之第一穩定劑組分及選自一或多種主抗氧化劑、檸檬酸或其組合之第二穩定劑組分。In one category of this embodiment or any other embodiment, category or subcategory combination of this fourth aspect, the stabilizer includes a first stabilizer component selected from one or more co-antioxidants and a first stabilizer component selected from one or more co-antioxidants. Secondary stabilizer component of various primary antioxidants, citric acid, or combinations thereof.
在此實施例之一個類別中或與此第四態樣之任何其他實施例、類別或子類別組合,添加劑為有機酸、鹽、蠟、相容劑、生物降解促進劑、染料、顏料、著色劑、光澤控制劑、潤滑劑、抗氧化劑、黏度改質劑、抗真菌劑、防霾劑、抗衝擊改質劑、抗細菌劑、軟化劑、脫模劑或其組合。應注意,可針對組合物中之多個類別之組分識別相同類型之化合物或材料或將相同類型之化合物或材料包括於組合物中之多個類別之組分中。舉例而言,聚乙二醇(PEG)可充當增塑劑或作為並不充當增塑劑之添加劑,諸如親水性聚合物或生物降解促進劑,例如其中較低分子量PEG具有塑化作用且較高分子量PEG充當不具有塑化作用之親水性聚合物。In one category of this embodiment or in any other embodiment, category or subcategory combination of this fourth aspect, the additive is an organic acid, a salt, a wax, a compatibilizer, a biodegradation accelerator, a dye, a pigment, a coloring agents, gloss control agents, lubricants, antioxidants, viscosity modifiers, antifungal agents, anti-haze agents, impact modifiers, antibacterial agents, softeners, release agents or combinations thereof. It should be noted that the same type of compound or material may be identified for or included in multiple classes of components in a composition. For example, polyethylene glycol (PEG) may act as a plasticizer or as an additive that does not act as a plasticizer, such as a hydrophilic polymer or a biodegradation accelerator, for example where lower molecular weight PEG has a plasticizing effect and is more High molecular weight PEG acts as a hydrophilic polymer without plasticizing effect.
抗氧化劑可分類為若干類別,包括主抗氧化劑及助抗氧化劑。通常已知主抗氧化劑基本上充當自由基終止劑(清除劑)。通常已知助抗氧化劑在其分解成烷氧基及羥基自由基之前將氫過氧化物(ROOH)分解成非反應性產物。助抗氧化劑通常與自由基清除劑(主抗氧化劑)組合使用以實現協同抑制作用,且助AO用於延長酚型主AO之壽命。Antioxidants can be classified into several categories, including primary antioxidants and secondary antioxidants. It is generally known that primary antioxidants essentially act as free radical terminators (scavengers). Co-antioxidants are generally known to decompose hydroperoxides (ROOH) into non-reactive products before decomposing into alkoxy and hydroxyl radicals. Secondary antioxidants are usually used in combination with free radical scavengers (main antioxidants) to achieve synergistic inhibition, and secondary AO is used to extend the life of phenolic main AO.
「主抗氧化劑」為藉由經由氫轉移與過氧化物自由基反應而起作用以淬滅自由基的抗氧化劑。主抗氧化劑通常含有反應性羥基或胺基,諸如受阻酚及二級芳胺。主抗氧化劑之實例包括BHT,Irganox™ 1010、1076、1726、245、1098、259及1425;Ethanox™ 310、376、314及330;Evernox™ 10、76、1335、1330、3114、MD 1024、1098、1726、120、2246及565;Anox™ 20、29、330、70、IC-14及1315;Lowinox™ 520、1790、22IB46、22M46、44B25、AH25、GP45、CA22、CPL、HD98、TBM-6及WSP;Naugard™ 431、PS48、SP及445;Songnox™ 1010、1024、1035、1076 CP、1135 LQ、1290 PW、1330FF、1330PW、2590 PW及3114 FF;及ADK Stab AO-20、AO-30、AO-40、AO-50、AO-60、AO-80及AO-330。A "primary antioxidant" is an antioxidant that acts by reacting with peroxide radicals via hydrogen transfer to quench free radicals. Primary antioxidants often contain reactive hydroxyl or amine groups, such as hindered phenols and secondary aromatic amines. Examples of primary antioxidants include BHT, Irganox™ 1010, 1076, 1726, 245, 1098, 259 and 1425; Ethanox™ 310, 376, 314 and 330; Evernox™ 10, 76, 1335, 1330, 3114, MD 1024, 1098 , 1726, 120, 2246 and 565; Anox™ 20, 29, 330, 70, IC-14 and 1315; Lowinox™ 520, 1790, 22IB46, 22M46, 44B25, AH25, GP45, CA22, CPL, HD98, TBM-6 and WSP; Naugard™ 431, PS48, SP and 445; Songnox™ 1010, 1024, 1035, 1076 CP, 1135 LQ, 1290 PW, 1330FF, 1330PW, 2590 PW and 3114 FF; and ADK Stab AO-20, AO-30 , AO-40, AO-50, AO-60, AO-80 and AO-330.
「助抗氧化劑」通常稱作氫過氧化物分解劑。其藉由與氫過氧化物反應以將其分解成不為自由基的非反應性及熱穩定產物來起作用。其通常與主抗氧化劑結合使用。助抗氧化劑之實例包括有機磷(例如,亞磷酸酯、亞膦酸二酯)及有機硫類別之化合物。此等化合物之磷及硫原子與過氧化物反應以將過氧化物轉化成醇。助抗氧化劑之實例包括Ultranox 626、Ethanox™ 368、326及327;Doverphos ™ LPG11、LPG12、DP S-680、4、10、S480、S-9228、S-9228T;Evernox ™ 168及626;Irgafos™ 126及168;Weston™ DPDP、DPP、EHDP、PDDP、TDP、TLP及TPP;Mark™ CH 302、CH 55、TNPP、CH66、CH 300、CH 301、CH 302、CH 304及CH 305;ADK Stab 2112、HP-10、PEP-8、PEP-36、1178、135A、1500、3010、C及TPP;Weston 439、DHOP、DPDP、DPP、DPTDP、EHDP、PDDP、PNPG、PTP、PTP、TDP、TLP、TPP、398、399、430、705、705T、TLTTP及TNPP;Alkanox 240、626、626A、627AV、618F及619F;及Songnox™ 1680 FF、1680 PW及6280 FF。"Co-antioxidants" are often called hydroperoxide decomposers. It works by reacting with hydroperoxides to break them down into non-reactive and thermally stable products that are not free radicals. It is often used in combination with primary antioxidants. Examples of co-antioxidants include compounds of the organophosphorus (eg, phosphite, phosphonite diester) and organosulfur classes. The phosphorus and sulfur atoms of these compounds react with the peroxide to convert the peroxide to alcohol. Examples of co-antioxidants include Ultranox 626, Ethanox™ 368, 326 and 327; Doverphos™ LPG11, LPG12, DP S-680, 4, 10, S480, S-9228, S-9228T; Evernox™ 168 and 626; Irgafos™ 126 and 168; Weston™ DPDP, DPP, EHDP, PDDP, TDP, TLP and TPP; Mark™ CH 302, CH 55, TNPP, CH66, CH 300, CH 301, CH 302, CH 304 and CH 305; ADK Stab 2112 , HP-10, PEP-8, PEP-36, 1178, 135A, 1500, 3010, C and TPP; Weston 439, DHOP, DPDP, DPP, DPTDP, EHDP, PDDP, PNPG, PTP, PTP, TDP, TLP, TPP, 398, 399, 430, 705, 705T, TLTTP and TNPP; Alkanox 240, 626, 626A, 627AV, 618F and 619F; and Songnox™ 1680 FF, 1680 PW and 6280 FF.
在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,氣味改質劑可選自:香草精、薄荷油M-1178、杏仁、苯烯丙基、香辛料、香辛料提取物、揮發性有機化合物或小分子及質體(Plastidor)。在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,氣味改質劑為香草精。In one of the subcategories of this category or in any other embodiment, category or subcategory combination of this fourth aspect, the odor modifier may be selected from: Vanilla Extract, Peppermint Oil M-1178, Almond, Phenyl Allyl , spices, spice extracts, volatile organic compounds or small molecules and plastidor. In one of the subcategories of this category or any other embodiment, category or subcategory combination of this fourth aspect, the odor modifier is vanilla extract.
在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,按組合物之總重量計,氣味改質劑之存在量為0.01至1 wt%,或0.1至0.5 wt%,或0.1至0.25wt%,或0.1至0.2 wt%。氣味改質添加劑之機制可包括掩蔽、捕獲、補充或此等之組合。In one of the subclasses of this class or any other embodiment, class or subclass combination of this fourth aspect, the odor modifying agent is present in an amount from 0.01 to 1 wt%, based on the total weight of the composition, or 0.1 to 0.5 wt%, or 0.1 to 0.25 wt%, or 0.1 to 0.2 wt%. The mechanism of odor-modifying additives may include masking, trapping, supplementation, or a combination of these.
在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,相容劑為非反應性相容劑或反應性相容劑。相容劑可增強MCE或另一組分達至所要小粒度之能力,以改良組合物中之所選擇組分之分散。In one of the sub-categories of this category or in any other embodiment, category or sub-category combination of this fourth aspect, the compatibilizer is a non-reactive compatibilizer or a reactive compatibilizer. Compatibilizers enhance the ability of MCE or another component to achieve a desired small particle size to improve dispersion of selected components in the composition.
在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,按組合物之重量計,相容劑之存在量為約1至約40 wt%,或約1至約30 wt%,或約1至約20 wt%,或約1至約10 wt%,或約5至約20 wt%,或約5至約10 wt%,或約10至約30 wt%,或約10至約20 wt%。In one of the subclasses of this class or any other embodiment, class or subclass combination of this fourth aspect, the compatibilizer is present in an amount from about 1 to about 40 wt %, based on the weight of the composition, or About 1 to about 30 wt%, or about 1 to about 20 wt%, or about 1 to about 10 wt%, or about 5 to about 20 wt%, or about 5 to about 10 wt%, or about 10 to about 30 wt% wt%, or about 10 to about 20 wt%.
在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,鹽為鹼土金屬氧化物、鹼土金屬氫氧化物、鹼土金屬碳酸鹽、鹼金屬碳酸鹽、鹼金屬碳酸氫鹽、ZnO及鹼性A l2O 3。在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,鹽為MgO、Mg(OH) 2、MgCO 3、CaO、Ca(OH) 2、CaCO 3、NaHCO 3、Na 2CO 3、K 2CO 3、ZnOKHCO 3或鹼性Al 2O 3。 In one of the subclasses of this class or any other embodiment, class or subclass combination of this fourth aspect, the salt is an alkaline earth metal oxide, an alkaline earth metal hydroxide, an alkaline earth metal carbonate, an alkali metal carbonate, Alkali metal bicarbonate, ZnO and basic Al2 O 3 . In one of the subclasses of this class or in any other embodiment, class or subclass combination of this fourth aspect, the salt is MgO, Mg(OH) 2 , MgCO3 , CaO, Ca(OH) 2 , CaCO3 , NaHCO 3 , Na 2 CO 3 , K 2 CO 3 , ZnOKHCO 3 or alkaline Al 2 O 3 .
在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,有機酸為乙酸、丙酸、丁酸、戊酸、檸檬酸、酒石酸、草酸、蘋果酸、苯甲酸、甲酸酯、乙酸酯、丙酸酯、丁酸酯、戊酸酯檸檬酸酯、酒石酸鹽、草酸鹽、蘋果酸鹽、順丁烯二酸、順丁烯二酸酯、鄰苯二甲酸、鄰苯二甲酸酯、苯甲酸酯及其組合。In one of the subclasses of this class or any other embodiment, class or subclass combination of this fourth aspect, the organic acid is acetic acid, propionic acid, butyric acid, valeric acid, citric acid, tartaric acid, oxalic acid, malic acid , benzoic acid, formate, acetate, propionate, butyrate, valerate citrate, tartrate, oxalate, malate, maleic acid, maleate , phthalates, phthalates, parabens, and combinations thereof.
在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,生物降解促進劑可包括二醇、聚乙二醇、聚醚及多元醇,或其他可生物降解聚合物,諸如聚(乙醇酸)、聚(乳酸)、聚乙二醇、聚丙二醇、聚二㗁烷、聚草酸酯、聚(α-羥基酯)、聚碳酸酯、聚酸酐、聚縮醛、聚己內酯、聚(原酸酯)、聚胺基酸、脂肪族聚酯(諸如聚(丁二醇)琥珀酸酯、聚(乙二醇)琥珀酸酯)、澱粉、再生纖維素或脂肪族-芳族聚酯,諸如PBAT。In one of the subcategories of this category or in any other embodiment, category or combination of subcategories of this fourth aspect, the biodegradation accelerator may include glycols, polyethylene glycols, polyethers and polyols, or other possible Biodegradable polymers such as poly(glycolic acid), poly(lactic acid), polyethylene glycol, polypropylene glycol, polydioxane, polyoxalate, poly(alpha-hydroxyester), polycarbonate, polyanhydride, Polyacetal, polycaprolactone, poly(orthoester), polyamino acid, aliphatic polyester (such as poly(butylene glycol) succinate, poly(ethylene glycol) succinate), starch, Regenerated cellulose or aliphatic-aromatic polyester such as PBAT.
在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,著色劑可包括碳黑、諸如紅色或藍色氧化鐵之氧化鐵、二氧化鈦、二氧化矽、鎘紅、碳酸鈣、高嶺黏土、氫氧化鋁、硫酸鋇、氧化鋅、氧化鋁及有機顏料(諸如偶氮基及重氮基及疊氮基顏料)、縮合偶氮、偶氮色澱、萘酚顏料、蒽嘧啶、苯并咪唑酮、咔唑、二酮基吡咯并吡咯、黃士酮、靛藍顏料、異吲哚啉酮、異吲哚啉、異紫蒽酮、金屬錯合物顏料、㗁𠯤、苝、哌瑞酮、皮蒽酮、吡唑并喹唑酮、喹啉黃、三芳基金炭顏料、三苯二㗁𠯤、𠮿、硫靛、靛蒽醌、異靛蒽醌、蒽嵌蒽醌、蒽醌、異雙苯駢蒽醌、三苯二㗁𠯤、喹吖啶酮及酞菁系列,尤其銅酞菁及其核鹵化衍生物,且亦酸、鹼性及媒染染料之色澱,及異吲哚啉酮顏料,以及植株及植物染料,及任何其他可用著色劑或染料。In one of the subclasses of this class or in any other embodiment, class or subclass combination of this fourth aspect, the colorant may include carbon black, iron oxide such as red or blue iron oxide, titanium dioxide, silicon dioxide , cadmium red, calcium carbonate, kaolin clay, aluminum hydroxide, barium sulfate, zinc oxide, aluminum oxide and organic pigments (such as azo-based and diazo-based and azido-based pigments), condensed azo, azo lake, Naphthol pigments, anthrapyrimidines, benzimidazolones, carbazoles, diketopyrrolopyrrole, xanthine, indigo pigments, isoindolinone, isoindoline, isoviolantthrone, metal complex pigments , 㗁𠯤, perylene, peridone, pithrone, pyrazoquinazolone, quinoline yellow, triaryl based carbon pigment, triphenyl dibenzoyl 𠯤, 𠮿 , thioindigo, indigoanthraquinone, isoindigoanthraquinone, anthraquinone, anthraquinone, isobiphenylparaanthraquinone, triphenyldimethacinone, quinacridone and phthalocyanine series, especially copper phthalocyanine and its core Halogenated derivatives, and also lakes of acid, basic and mordant dyes, and isoindolinone pigments, as well as plant and vegetable dyes, and any other available colorants or dyes.
在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,光澤控制劑可包括矽石、滑石、黏土、硫酸鋇、碳酸鋇、硫酸鈣、碳酸鈣、碳酸鎂及類似物。In one of the subclasses of this class or any other embodiment, class or subclass combination of this fourth aspect, the gloss control agent may include silica, talc, clay, barium sulfate, barium carbonate, calcium sulfate, calcium carbonate , magnesium carbonate and the like.
在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,抗真菌劑及/或抗細菌劑包括多烯抗真菌劑(例如,遊黴素、龜裂黴素、非律平(filipin)、耐絲菌素、雙性黴素B、坎底辛(candicin)及哈黴素)、諸如咪康唑之咪唑抗真菌劑(可作為MICATIN®自WellSpring Pharmaceutical公司獲得)、酮康唑(可作為NIZORAL®自McNeil consumer Healthcare商購)、克氯黴唑(可作為可購自Merck之LOTRAMIN®及LOTRAMIN AF®及可購自Bayer之CANESTEN®而商購)、益康唑、奧莫康唑、聯苯苄唑、布康唑、芬替康唑、異康唑、奧昔康唑、舍他康唑(可作為ERTACZO®自OrthoDematologics商購)、硫康唑及噻康唑;三唑抗真菌劑,諸如氟康唑、伊曲康唑、艾沙康唑、拉夫康唑、泊沙康唑、伏立康唑、特康唑及阿巴康唑、噻唑抗真菌劑(例如,阿巴芬淨)、烯丙胺抗真菌劑(例如,特比萘芬(可作為LAMISIL®自Novartis Consumer Health公司商購)、萘替芬(可作為可購自Merz Pharmaceuticals之NAFTIN®而商購)及布替萘芬(可作為LOTRAMIN ULTRA®自Merck商購))、棘白菌素抗真菌劑(例如,阿尼芬淨、卡泊芬淨及米卡芬淨)、水蓼二醛(polygodial)、苯甲酸、環吡酮、托萘酯(例如,可作為TINACTIN®自MDS Consumer Care公司商購)、十一碳烯酸、氟胞嘧啶、5-氟胞嘧啶、灰黃黴素、鹵苯炔醚、辛酸及其任何組合。In one of the subclasses of this class or in any other embodiment, class or subclass combination of this fourth aspect, antifungal and/or antibacterial agents include polyene antifungals (e.g., natamycin, natamycin, Filipin, filipin, nitrothricin, amphotericin B, candicin, and hammycin), imidazole antifungals such as miconazole (available as MICATIN® from WellSpring Pharmaceutical), ketoconazole (commercially available as NIZORAL® from McNeil Consumer Healthcare), clotrimazole (commercially available as LOTRAMIN® and LOTRAMIN AF® from Merck and CANESTEN® from Bayer ), econazole, omeconazole, bifonazole, butoconazole, fenticonazole, isoconazole, oxyconazole, sertaconazole (commercially available as ERTACZO® from OrthoDematologics), sulfur Conazole and tioconazole; triazole antifungals such as fluconazole, itraconazole, isavuconazole, lavconazole, posaconazole, voriconazole, terconazole and abaconazole, thiazole antifungals Fungal agents (e.g., abafungin), allylamine antifungals (e.g., terbinafine (commercially available as LAMISIL® from Novartis Consumer Health), naftifine (commercially available as NAFTIN from Merz Pharmaceuticals ®) and butenafine (commercially available as LOTRAMIN ULTRA® from Merck), echinocandin antifungals (e.g., anidulafungin, caspofungin, and micafungin), water Polygodial, benzoic acid, ciclopirox, tolnaftate (e.g., commercially available as TINACTIN® from MDS Consumer Care), undecenoic acid, flucytosine, 5-fluorocytosine, ash Flavomycin, halobenzinyl ethers, octanoic acid and any combination thereof.
在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,具有改質可使用之組合物之熔融流動指數或黏度的目的之黏度改質劑包括聚乙二醇及聚丙二醇,及甘油。In one of the subcategories of this category or in any other embodiment, category or combination of subcategories of this fourth aspect, viscosity modifiers having the purpose of modifying the melt flow index or viscosity of the compositions in which they may be used include polymers. Ethylene glycol and polypropylene glycol, and glycerin.
在此類別之一個子類別中或與此第四態樣之任何其他實施例、類別或子類別組合,脫模劑或潤滑劑(例如脂肪酸、乙二醇二硬脂酸酯)、防黏或助滑劑(例如脂肪酸酯、金屬硬脂酸鹽(例如,硬脂酸鋅),及蠟)、防霧劑(例如界面活性劑)、熱穩定劑(例如環氧穩定劑、環氧化大豆油(ESBO)之衍生物、亞麻籽油及葵花籽油)、抗靜電劑、發泡劑、殺生物劑、抗衝擊改質劑或加強纖維。In one of the subclasses of this class or in any other embodiment, class or subclass combination of this fourth aspect, a release agent or lubricant (e.g. fatty acid, ethylene glycol distearate), anti-stick or Slip agents (such as fatty acid esters, metal stearates (such as zinc stearate), and waxes), anti-fogging agents (such as surfactants), heat stabilizers (such as epoxy stabilizers, epoxy stabilizers) Derivatives of soybean oil (ESBO), linseed oil and sunflower oil), antistatic agents, foaming agents, biocides, impact modifiers or reinforcing fibers.
崩解與生物降解 一般而言,降解之後為測定諸如溶解有機碳(DOC)、CO 2產生及攝氧量之參數。存在三種用於測試材料之生物降解的主要方法:史徒木(Sturm)方法、呼吸測定方法及經放射性標記之 14C原子測試方法。史徒木方法經由壓力變化準確地量測二氧化碳產生。呼吸測定法測試準確地量測60天之耗氧量。最後,經放射性標記之 14C原子測試測定 14C至 14CO 2之轉化率。若使用右側設備,則全部三種方法可在水生或堆肥條件下使用。 Disintegration and Biodegradation Generally, degradation is followed by determination of parameters such as dissolved organic carbon (DOC), CO2 production and oxygen uptake. There are three main methods for testing the biodegradation of materials: the Sturm method, the respiration method, and the radioactively labeled 14 C atom test method. The Stork method accurately measures carbon dioxide production via pressure changes. Respirometry tests accurately measure oxygen consumption over 60 days. Finally, the conversion rate of 14 C to 14 CO 2 is determined by testing radioactively labeled 14 C atoms. With the device on the right, all three methods can be used in aquatic or composting conditions.
淡水改質史徒木測試(OECD 301B) 作為理論產量之百分比(基於總有機碳分析)產生之二氧化碳(CO 2)的量用作用於評估材料是否生物降解的基礎。藉助於氫氧化鈉捕集器來量測CO 2。研究進行最少28天且可在CO 2產量顯示朝向28天時間段結束時增加之跡象時繼續。 Freshwater Modified Stork Test (OECD 301B) The amount of carbon dioxide (CO 2 ) produced as a percentage of the theoretical yield (based on total organic carbon analysis) is used as the basis for assessing whether a material biodegrades. CO 2 is measured by means of a sodium hydroxide trap. The study is conducted for a minimum of 28 days and may be continued if CO2 production shows signs of increasing towards the end of the 28 day period.
生物降解測試- O 2消耗量(OECD 301F)可用於監視聚合材料之生物降解。OECD 301F為水生好氧生物降解測試,其藉由量測耗氧量測定材料之可生物降解性。OECD 301F最常用於經OECD 301B測試刺激之不可溶及揮發性材料。測試材料之主要組分之純度或比例對於計算理論需氧量(ThOD)而言至關重要。如同其他OECD 301測試方法,OECD 301F之標準測試持續時間最少為28天且可量測備用或固有可生物降解性。接種測試物質於礦物培養基中之溶液或懸浮液,且在好氧性條件下在暗處或在漫射光中培育。並行地進行參考化合物(通常為乙酸鈉或苯甲酸鈉)以檢查程序之操作。 Biodegradation test - O2 consumption (OECD 301F) can be used to monitor the biodegradation of polymeric materials. OECD 301F is an aquatic aerobic biodegradation test, which determines the biodegradability of materials by measuring oxygen consumption. OECD 301F is most commonly used for insoluble and volatile materials that are subject to test irritation by OECD 301B. The purity or proportions of the major components of the test material are critical to calculating the theoretical oxygen demand (ThOD). Like other OECD 301 test methods, OECD 301F's standard test duration is at least 28 days and can measure reserve or inherent biodegradability. A solution or suspension of the test substance in a mineral medium is inoculated and incubated under aerobic conditions in the dark or in diffuse light. A reference compound (usually sodium acetate or sodium benzoate) is run in parallel to check the operation of the procedure.
存在三種可生物降解性之分類:容易可生物降解、固有可生物降解且不可生物降解。若材料在28天內達至其理論需氧量之≥60%,則其為容易可生物降解。僅在已經過28天窗口之後,固有可生物降解材料亦達到60%程度。通常,對容易可生物降解之材料之測試持續28天,而延長之測試期可用於將材料分類為固有可生物降解。There are three classifications of biodegradability: readily biodegradable, inherently biodegradable and non-biodegradable. A material is readily biodegradable if it reaches ≥60% of its theoretical oxygen demand within 28 days. Only after the 28-day window has passed, the inherently biodegradable material reaches the 60% level. Typically, testing of readily biodegradable materials lasts for 28 days, and extended testing periods can be used to classify materials as inherently biodegradable.
OxiTop方法為一種用以分析生物降解同時報告可生物降解性作為耗氧量,將在測試期間產生之CO 2之壓力轉化成對生物需氧量BOD之測試的改質史徒木方法。OxiTop以易於使用之格式為水生生物降解提供精確量測。使用OxiTop®對照OC 110呼吸測定計系統隨時間推移量測生物需氧量[BOD]。此藉由量測在封閉式瓶子系統中消耗氧氣時產生的負壓來實現。將NaOH錠劑添加至系統中以收集在O 2耗盡時放出之CO 2。CO 2及NaOH反應以形成Na 2CO 3,從而將CO 2自氣相分離出來且引起可量測之負壓。OxiTop量測頭記錄此負壓值且以無線方式將資訊轉送至控制器,控制器歸因於1:1比率而將產生之CO 2轉化成BOD。所量測之生物需氧量可與各測試材料之理論需氧量相比以測定生物降解百分比。OxiTop可用以篩檢材料以實現備用或固有可生物降解性。 The OxiTop method is a modified Stork method used to analyze biodegradation while reporting biodegradability as oxygen consumption, converting the pressure of CO2 generated during the test into a measurement of biological oxygen demand (BOD). OxiTop provides accurate measurement of aquatic biodegradation in an easy-to-use format. Measure biological oxygen demand [BOD] over time using the OxiTop® Control OC 110 Respirometer System. This is accomplished by measuring the negative pressure created when oxygen is consumed in a closed bottle system. NaOH pellets were added to the system to collect the CO2 evolved as the O2 was depleted. CO 2 and NaOH react to form Na 2 CO 3 , thereby separating CO 2 from the gas phase and causing a measurable negative pressure. The OxiTop measuring head records this negative pressure value and wirelessly transmits the information to the controller, which converts the generated CO 2 into BOD thanks to a 1:1 ratio. The measured biological oxygen demand can be compared to the theoretical oxygen demand of each test material to determine the percent biodegradation. OxiTop can be used to screen materials for reserve or inherent biodegradability.
在第五態樣中,本申請案亦揭示一種包含先前所揭示混合纖維素酯中之任一者的製品。In a fifth aspect, the present application also discloses an article comprising any of the previously disclosed mixed cellulose esters.
在第六態樣中,本申請案亦揭示一種包含先前所揭示混合纖維素酯中之任一者的珠粒。In a sixth aspect, the present application also discloses beads comprising any of the previously disclosed mixed cellulose esters.
在一個實施例中或與此第六態樣之任何其他實施例、類別或子類別組合,珠粒的直徑為0.5至100微米,或0.5至50微米,或0.5至40微米,或0.5至30微米,或0.5至20微米,或0.5至10微米,或1至100微米,或1至70微米,或1至60微米,或1至50微米,1至52微米,或1至40微米,或1至30微米,或1至20微米,或1至10微米。In one embodiment or any other embodiment, class or subclass combination of this sixth aspect, the diameter of the beads is 0.5 to 100 microns, or 0.5 to 50 microns, or 0.5 to 40 microns, or 0.5 to 30 microns. microns, or 0.5 to 20 microns, or 0.5 to 10 microns, or 1 to 100 microns, or 1 to 70 microns, or 1 to 60 microns, or 1 to 50 microns, 1 to 52 microns, or 1 to 40 microns, or 1 to 30 microns, or 1 to 20 microns, or 1 to 10 microns.
在一個實施例中或與此第六態樣之任何其他實施例、類別或子類別組合,珠粒展現如下球形度:50至100%,或60至100%,或70至100%,或80至100%,或90至100%,或50至90%,或50至80%,或50至70%,或60至90%,或60至80%,或60至70%,或70至90%,或70至80%,或80至90%,或至少70%,或至少80%,或至少90%。可根據美國專利公開案第2020/0299488號中所揭示之程序測定球形度。In one embodiment or any other embodiment, class or subclass combination of this sixth aspect, the beads exhibit a sphericity of: 50 to 100%, or 60 to 100%, or 70 to 100%, or 80 to 100%, or 90 to 100%, or 50 to 90%, or 50 to 80%, or 50 to 70%, or 60 to 90%, or 60 to 80%, or 60 to 70%, or 70 to 90 %, or 70 to 80%, or 80 to 90%, or at least 70%, or at least 80%, or at least 90%. Sphericity can be determined according to the procedure disclosed in US Patent Publication No. 2020/0299488.
在一個實施例中或與此第六態樣之任何其他實施例、類別或子類別組合,如使用測試方法ASTM D281所量測,珠粒展現如下吸油量:至少每100 g 30 mL或每100 g 35 mL,或每100 g 40 mL,或每100 g 45 mL,或每100 g 50 mL,或每100 g 55 mL,或每100 g 60 mL,其中使用礦物油替代蓖麻油。In one embodiment or any other embodiment, category or subcategory combination of this sixth aspect, the beads exhibit the following oil absorption as measured using test method ASTM D281: at least 30 mL per 100 g or per 100 g 35 mL, or 40 mL per 100 g, or 45 mL per 100 g, or 50 mL per 100 g, or 55 mL per 100 g, or 60 mL per 100 g, where mineral oil is used instead of castor oil.
在一個實施例中或與此第六態樣之任何其他實施例、類別或子類別組合,珠粒進一步包含乙酸纖維素,其中乙酸纖維素對於乙醯基取代基的平均取代度(「DS Ac」)為1.5至2.6。在此實施例之一個類別中,DS Ac為1.8至2.2,或1.5至2.0,或1.8至2.0,或2.0至2.2。 In one embodiment or any other embodiment, class or subclass combination of this sixth aspect, the beads further comprise cellulose acetate, wherein the cellulose acetate has an average degree of substitution for the acetyl substituent ("DS Ac ”) is 1.5 to 2.6. In one category of this embodiment, DS Ac is 1.8 to 2.2, or 1.5 to 2.0, or 1.8 to 2.0, or 2.0 to 2.2.
在第七態樣中,本申請案亦揭示一種包含本文先前所揭示之複數個珠粒的組合物。In a seventh aspect, the present application also discloses a composition comprising a plurality of beads previously disclosed herein.
在一個實施例中或與此第七態樣之任何其他實施例、類別或子類別組合,如使用測試方法ASTM D281所量測,珠粒展現如下吸油量:至少每100 g 30 mL或每100 g 35 mL,或每100 g 40 mL,或每100 g 45 mL,或每100 g 50 mL,或每100 g 55 mL,或每100 g 60 mL,其中使用礦物油替代蓖麻油。In one embodiment, or any other embodiment, category, or subcategory combination of this seventh aspect, the beads exhibit the following oil absorption as measured using test method ASTM D281: at least 30 mL per 100 g or per 100 g 35 mL, or 40 mL per 100 g, or 45 mL per 100 g, or 50 mL per 100 g, or 55 mL per 100 g, or 60 mL per 100 g, where mineral oil is used instead of castor oil.
在第八態樣中,本申請案亦揭示一種包含先前所揭示混合纖維素酯中之任一者的膜。In an eighth aspect, the present application also discloses a film comprising any of the previously disclosed mixed cellulose esters.
具有所需光學屬性之膜可用作補償膜。四分之一波片為其中平面內延遲(「R e」)等於用於量測平面內延遲的光波長的四分之一的膜。 Films with desired optical properties can be used as compensation films. A quarter-wave plate is a film in which the in-plane retardation ("R e ") is equal to one-quarter of the wavelength of light used to measure the in-plane retardation.
在一個實施例中或與任何其他實施例組合,膜為反向色散四分之一波片。In one embodiment or in combination with any other embodiment, the film is a reverse dispersion quarter wave plate.
膜可藉由溶劑澆鑄、熔融擠壓、層壓或塗佈製程形成。此等程序一般為此項技術中已知的。溶劑澆鑄、熔融擠壓、層壓及塗佈方法之實例可見於例如美國專利申請公開案第US 2009/0050842號、US 2009/0054638號及US 2009/0096962號中,其內容以引用之方式併入本文中。形成膜之溶劑澆鑄、熔融擠壓、層壓及塗佈方法之其他實例可見於例如美國專利第4,592,885號及第7,172,713號以及美國專利申請公開案第US 2005/0133953號及第US 2010/0055356號中,其內容以引用之方式併入本文中。Films can be formed by solvent casting, melt extrusion, lamination or coating processes. Such procedures are generally known in the art. Examples of solvent casting, melt extrusion, lamination and coating methods can be found, for example, in U.S. Patent Application Publication Nos. US 2009/0050842, US 2009/0054638, and US 2009/0096962, the contents of which are incorporated by reference. into this article. Other examples of solvent casting, melt extrusion, lamination and coating methods to form films can be found in, for example, U.S. Patent Nos. 4,592,885 and 7,172,713 and U.S. Patent Application Publication Nos. US 2005/0133953 and US 2010/0055356 , the contents of which are incorporated herein by reference.
在一個實施例中或與任何其他實施例組合,膜展現:(i) 125 nm至145 nm範圍內之R e(550nm);(ii) -65 nm至-100 nm範圍內之R th(550nm);(iii) 0.85至0.98範圍內之R e(450nm)/R e(550nm);(iv) 1.07至0.96範圍內之R e(650nm)/R e(550nm);(v) 35微米至80微米之膜厚度(「d」);及(vi)小於1%之混濁度%,其中R e(450nm)、R e(550nm)及R e(650nm)分別為在450 nm、550 nm及650 nm之光波長下量測的平面內延遲,且R th(550nm)為在550 nm之光波長下量測的平面外延遲。 In one embodiment or in combination with any other embodiment, the film exhibits: (i) R e (550 nm) in the range of 125 nm to 145 nm; (ii) R th (550 nm) in the range of -65 nm to -100 nm ); (iii) Re (450nm ) /R e (550nm) in the range of 0.85 to 0.98; (iv) Re (650nm)/ R e ( 550nm) in the range of 1.07 to 0.96; (v) 35 micron to Film thickness (“d”) of 80 microns; and (vi) haze % less than 1%, where R e (450 nm), R e (550 nm) and R e (650 nm) are at 450 nm, 550 nm and R e (650 nm) respectively. The in-plane retardation is measured at a light wavelength of 650 nm, and R th (550 nm) is the out-of-plane retardation measured at a light wavelength of 550 nm.
在一個實施例中或與任何其他實施例組合,膜經單軸、雙軸或45度拉伸。In one embodiment or in combination with any other embodiment, the film is uniaxially, biaxially or 45 degree stretched.
在一個實施例中或與任何其他實施例組合,膜在加工方向(「MD」)上以0.7至1的比率及在橫向方向(「TD」)上以1至2的比率雙軸或45度拉伸。In one embodiment or in combination with any other embodiment, the film is biaxial or 45 degrees in the machine direction ("MD") at a ratio of 0.7 to 1 and in the transverse direction ("TD") at a ratio of 1 to 2 Stretch.
在一個實施例中或與任何其他實施例組合,膜進一步包含5至25 wt%之包含芳族部分的增塑劑。在此實施例之一個類別中,增塑劑為二((C 1-10)烷基)鄰苯二甲酸酯或磷酸三苯酯。 In one embodiment or in combination with any other embodiment, the film further comprises 5 to 25 wt% of a plasticizer comprising an aromatic moiety. In one category of this embodiment, the plasticizer is di((C 1-10 )alkyl) phthalate or triphenyl phosphate.
在一個實施例中或與任何其他實施例組合,膜為反向色散四分之一波片,其包含:(A)混合纖維素酯(「MCE」),其包含(1)複數個乙醯基取代基、(2)複數個丁醯基取代基及(3)複數個羥基取代基,其中MCE對於乙醯基取代基的平均取代度(「DS Ac」)為2.05至2.2,MCE對於丁醯基取代基的平均取代度(「DS Bu」)為0.18至0.25,MCE對於羥基取代基的平均取代度(「DS OH」)為0.54至0.6;及(B) 5至25 wt%之作為二((C 1-10)烷基)鄰苯二甲酸酯或二苯基磷酸酯的增塑劑,其中膜展現(i) 125 nm至145 nm範圍內之R e(550nm)、(ii) -65 nm至-100 nm範圍內之R th(550nm)、(iii) 0.85至0.98範圍內之R e(450nm)/R e(550nm)、(iv) 1.07至0.96範圍內之R e(650nm)/R e(550nm)、(v) 35微米至80微米之膜厚度(「d」)及(vi)小於1%之混濁度%,其中R e(450nm)、R e(550nm)及R e(650nm)分別為在450 nm、550 nm及650 nm之光波長下量測的平面內延遲,且R th(550nm)為在550 nm之光波長下量測的平面外延遲。 In one embodiment or in combination with any other embodiment, the film is a reverse dispersion quarter wave plate comprising: (A) mixed cellulose esters ("MCE") comprising (1) a plurality of acetyl base substituent, (2) a plurality of butyl substituents and (3) a plurality of hydroxyl substituents, wherein the average degree of substitution ("DS Ac ") of MCE for the acetyl substituent is 2.05 to 2.2, and the MCE for the butyl substituent The average degree of substitution ("DS Bu ") of MCE for hydroxyl substituents ("DS OH ") is 0.18 to 0.25, and the average degree of substitution of MCE for hydroxyl substituents ("DS OH") is 0.54 to 0.6; and (B) 5 to 25 wt% as two ((C 1-10 ) Plasticizers of alkyl) phthalates or diphenyl phosphates, wherein the film exhibits (i) R e (550 nm) in the range of 125 nm to 145 nm, (ii) -65 nm to R th (550nm) in the range of -100 nm, (iii) R e (450nm)/R e (550nm) in the range of 0.85 to 0.98, (iv) R e (650nm)/R in the range of 1.07 to 0.96 e (550nm), (v) film thickness (“d”) from 35 microns to 80 microns and (vi) turbidity % less than 1%, where R e (450nm), R e (550nm) and R e (650nm) ) are the in-plane retardations measured at light wavelengths of 450 nm, 550 nm, and 650 nm, respectively, and R th (550 nm) is the out-of-plane retardation measured at the light wavelength of 550 nm.
在此實施例之一個類別中,膜在加工方向(「MD」)上以0.7至1的比率及在橫向方向(「TD」)上以1至2的比率雙軸或45度拉伸。In one category of this embodiment, the film is biaxially or 45-degree stretched at a ratio of 0.7 to 1 in the machine direction ("MD") and at a ratio of 1 to 2 in the transverse direction ("TD").
在第九態樣中,本申請案亦揭示一種由先前所揭示組合物或混合纖維素酯中之任一者製備的膜。In a ninth aspect, the present application also discloses a film prepared from any of the previously disclosed compositions or mixed cellulose esters.
在一個實施例中或與此第九態樣之任何其他實施例、類別或子類別組合,其中組合物進一步包含1至40 wt%之乙酸纖維素,其中乙酸纖維素展現1.5至2.6之對於乙醯基取代基的平均取代度。在此實施例之一個類別中,DS Ac為1.8至2.2,或1.5至2.0,或1.8至2.0,或2.0至2.2。 In one embodiment or any other embodiment, category or subcategory combination of this ninth aspect, wherein the composition further comprises 1 to 40 wt% cellulose acetate, wherein the cellulose acetate exhibits 1.5 to 2.6 for acetate Average degree of substitution of acyl substituents. In one category of this embodiment, DS Ac is 1.8 to 2.2, or 1.5 to 2.0, or 1.8 to 2.0, or 2.0 to 2.2.
在第十態樣中,本申請案亦揭示由纖維素酯組合物形成之纖維素酯粒子,該纖維素酯組合物包含:(I)混合纖維素酯(「MCE」),其包含(1)複數個乙醯基取代基、(2)複數個(C 2-3)烷基-CO-取代基及(3)複數個羥基取代基,其中MCE對於乙醯基取代基的平均取代度(「DS Ac」)為0.6至2.4,MCE對於(C 2-3)烷基-CO-取代基的平均取代度(「DS AkCO」)為0.1至1.1,MCE對於羥基取代基的平均取代度(「DS OH」)為0.55至1.5;及(II)乙酸纖維素(「CA」),其包含複數個乙醯基取代基及複數個羥基取代基,其中CA對於乙醯基取代基的平均取代度(「DS Ac」)為1.5至2.6,CA對於羥基取代基的平均取代度(「DS OH」)為0.4至1.5。 In a tenth aspect, the present application also discloses cellulose ester particles formed from a cellulose ester composition comprising: (I) a mixed cellulose ester ("MCE") comprising (1 ) a plurality of acetyl substituents, (2) a plurality of (C 2-3 ) alkyl-CO- substituents and (3) a plurality of hydroxyl substituents, where the average degree of substitution of MCE for the acetyl substituent is ( "DS Ac ") is 0.6 to 2.4, the average degree of substitution of MCE for the (C 2-3 ) alkyl-CO- substituent ("DS AkCO ") is 0.1 to 1.1, and the average degree of substitution of MCE for the hydroxyl substituent is ( "DS OH ") is 0.55 to 1.5; and (II) cellulose acetate ("CA"), which contains a plurality of acetyl substituents and a plurality of hydroxyl substituents, wherein the average substitution of CA for the acetyl substituent degree ("DS Ac ") is 1.5 to 2.6, and the average degree of substitution of CA for the hydroxyl substituent ("DS OH ") is 0.4 to 1.5.
在一個實施例中或與此第十態樣之任何其他實施例、類別或子類別組合,(C 2-3)烷基-CO-為丙醯基。在一個實施例中或與此第十態樣之任何其他實施例、類別或子類別組合,(C 2-3)烷基-CO-為丁醯基。 In one embodiment or any other embodiment, category or subcategory combination of this tenth aspect, (C 2-3 )alkyl-CO- is propyl. In one embodiment or any other embodiment, category or subcategory combination of this tenth aspect, (C 2-3 )alkyl-CO- is butylyl.
在一個實施例中或與此第十態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以60 wt%至99 wt%存在,且CA以1 wt%至40 wt%存在。在一個實施例中或與此第十態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以55 wt%至99 wt%存在,且CA以1 wt%至45 wt%存在。在一個實施例中或與此第十態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以65 wt%至99 wt%存在,且CA以1 wt%至35 wt%存在。在一個實施例中或與此第十態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以70 wt%至99 wt%存在,且CA以1 wt%至30 wt%存在。在一個實施例中或與此第十態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以75 wt%至99 wt%存在,且CA以1 wt%至25 wt%存在。在一個實施例中或與此第十態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以80 wt%至99 wt%存在,且CA以1 wt%至20 wt%存在。在一個實施例中或與此第十態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以85 wt%至99 wt%存在,且CA以1 wt%至25 wt%存在。In one embodiment or any other embodiment, category or subcategory combination of this tenth aspect, the MCE is present at 60 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and the CA is present at 1 wt% to 40 wt% present. In one embodiment or any other embodiment, category or subcategory combination of this tenth aspect, MCE is present at 55 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and CA is present at 1 wt% to 45 wt% present. In one embodiment or any other embodiment, category or subcategory combination of this tenth aspect, the MCE is present at 65 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and the CA is present at 1 wt% to 35 wt% present. In one embodiment or any other embodiment, category or subcategory combination of this tenth aspect, MCE is present at 70 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and CA is present at 1 wt% to 30 wt% present. In one embodiment or any other embodiment, category or subcategory combination of this tenth aspect, the MCE is present at 75 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and the CA is present at 1 wt% to 25 wt% present. In one embodiment or any other embodiment, category or subcategory combination of this tenth aspect, MCE is present at 80 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and CA is present at 1 wt% to 20 wt% present. In one embodiment or any other embodiment, category or subcategory combination of this tenth aspect, the MCE is present at 85 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and the CA is present at 1 wt% to 25 wt% present.
在一個實施例中或與此第十態樣之任何其他實施例、類別或子類別組合,纖維素酯粒子展現以下中之至少一者:(i) 1微米至60微米之平均粒度;(ii) 0.2至0.7之體積密度;(iii) 0.1 m 2/g至10 m 2/g之平均表面積;或(iv) 70%至100%之球形度。 In one embodiment or any other embodiment, category or subcategory combination of this tenth aspect, the cellulose ester particles exhibit at least one of: (i) an average particle size of 1 micron to 60 microns; (ii) ) a bulk density of 0.2 to 0.7; (iii) an average surface area of 0.1 m 2 /g to 10 m 2 /g; or (iv) a sphericity of 70% to 100%.
在第十一態樣中,本申請案亦揭示一種摻雜組合物,其包含:(A)纖維素酯組合物:(I)混合纖維素酯(「MCE」),其包含(1)複數個乙醯基取代基、(2)複數個(C 2-3)烷基-CO-取代基及(3)複數個羥基取代基,其中:MCE對於乙醯基取代基的平均取代度(「DS Ac」)為0.6至2.4,MCE對於(C 2-3)烷基-CO-取代基的平均取代度(「DS AkCO」)為0.1至1.1,MCE對於羥基取代基的平均取代度(「DS OH」)為0.55至1.5,及(II)乙酸纖維素(「CA」),其包含:複數個乙醯基取代基;及複數個羥基取代基,其中:CA對於乙醯基取代基的平均取代度(「DS Ac」)為1.5至2.6,CA對於羥基取代基的平均取代度(「DS OH」)為0.4至1.5;及(B)溶劑,其中溶劑包含:(1)水、(2)乙酸(C 1-2)烷酯及(3) (C 1-5)烷醇,其中摻雜組合物展現3000至9000 cP範圍內之黏度。 In an eleventh aspect, the present application also discloses a doped composition comprising: (A) a cellulose ester composition: (I) a mixed cellulose ester ("MCE") comprising (1) plural acetyl substituents, (2) a plurality of (C 2-3 ) alkyl-CO- substituents and (3) a plurality of hydroxyl substituents, where: the average degree of substitution of MCE for the acetyl substituent (" DS Ac ") is 0.6 to 2.4, the average degree of substitution of MCE for (C 2-3 ) alkyl-CO- substituents ("DS AkCO ") is 0.1 to 1.1, and the average degree of substitution of MCE for hydroxyl substituents (" DS OH ") is 0.55 to 1.5, and (II) cellulose acetate ("CA"), which contains: a plurality of acetyl substituents; and a plurality of hydroxyl substituents, wherein: CA for the acetyl substituent The average degree of substitution ("DS Ac ") is 1.5 to 2.6, and the average degree of substitution of CA for the hydroxyl substituent ("DS OH ") is 0.4 to 1.5; and (B) a solvent, wherein the solvent includes: (1) water, ( 2) (C 1-2 ) alkyl acetate and (3) (C 1-5 ) alkanol, wherein the doped composition exhibits a viscosity in the range of 3000 to 9000 cP.
在一個實施例中或與此第十一態樣之任何其他實施例、類別或子類別組合,(C 2-3)烷基-CO-為丙醯基。在一個實施例中或與此第十一態樣之任何其他實施例、類別或子類別組合,(C 2-3)烷基-CO-為丁醯基。 In one embodiment or any other embodiment, category or subcategory combination of this eleventh aspect, (C 2-3 )alkyl-CO- is propyl. In one embodiment or any other embodiment, category or subcategory combination of this eleventh aspect, (C 2-3 )alkyl-CO- is butylyl.
在一個實施例中或與此第十一態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以60 wt%至99 wt%存在,且CA以1 wt%至40 wt%存在。在一個實施例中或與此第十一態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以55 wt%至99 wt%存在,且CA以1 wt%至45 wt%存在。在一個實施例中或與此第十一態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以65 wt%至99 wt%存在,且CA以1 wt%至35 wt%存在。在一個實施例中或與此第十一態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以70 wt%至99 wt%存在,且CA以1 wt%至30 wt%存在。在一個實施例中或與此第十一態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以75 wt%至99 wt%存在,且CA以1 wt%至25 wt%存在。在一個實施例中或與此第十一態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以80 wt%至99 wt%存在,且CA以1 wt%至20 wt%存在。在一個實施例中或與此第十一態樣之任何其他實施例、類別或子類別組合,按纖維素酯組合物之總重量計,MCE以85 wt%至99 wt%存在,且CA以1 wt%至25 wt%存在。In one embodiment or any other embodiment, category or subcategory combination of this eleventh aspect, MCE is present at 60 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and CA is present at Present from 1 wt% to 40 wt%. In one embodiment or any other embodiment, category or subcategory combination of this eleventh aspect, MCE is present in 55 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and CA is present in 1 wt% to 45 wt% present. In one embodiment or any other embodiment, category or subcategory combination of this eleventh aspect, MCE is present in 65 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and CA is present in 1 wt% to 35 wt% present. In one embodiment or any other embodiment, category or subcategory combination of this eleventh aspect, MCE is present at 70 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and CA is present at Present from 1 wt% to 30 wt%. In one embodiment or any other embodiment, category or subcategory combination of this eleventh aspect, MCE is present in 75 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and CA is present in 1 wt% to 25 wt% present. In one embodiment or any other embodiment, category or subcategory combination of this eleventh aspect, MCE is present at 80 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and CA is present at 1 wt% to 20 wt% present. In one embodiment or any other embodiment, category or subcategory combination of this eleventh aspect, MCE is present in 85 wt% to 99 wt%, based on the total weight of the cellulose ester composition, and CA is present in 1 wt% to 25 wt% present.
在一個實施例中或與此第十一態樣之任何其他實施例、類別或子類別組合,按摻雜組合物之總重量計,纖維素酯組合物以5 wt%至20 wt%存在,且溶劑以80 wt%至95 wt%存在。在一個實施例中或與此第十一態樣之任何其他實施例、類別或子類別組合,按摻雜組合物之總重量計,纖維素酯組合物以5 wt%至15 wt%存在,且溶劑以85 wt%至95 wt%存在。在一個實施例中或與此第十一態樣之任何其他實施例、類別或子類別組合,按摻雜組合物之總重量計,纖維素酯組合物以5 wt%至10 wt%存在,且溶劑以90 wt%至95 wt%存在。In one embodiment or any other embodiment, category or subcategory combination of this eleventh aspect, the cellulose ester composition is present in 5 wt% to 20 wt% based on the total weight of the doped composition, And the solvent is present at 80 wt% to 95 wt%. In one embodiment or any other embodiment, category or subcategory combination of this eleventh aspect, the cellulose ester composition is present in 5 wt% to 15 wt% based on the total weight of the doped composition, And the solvent is present at 85 wt% to 95 wt%. In one embodiment or any other embodiment, category or subcategory combination of this eleventh aspect, the cellulose ester composition is present in 5 wt% to 10 wt% based on the total weight of the doped composition, And the solvent is present at 90 wt% to 95 wt%.
在第十二態樣中,本申請案亦揭示一種有機發光二極體(「OLED」)顯示器,其包含先前所揭示膜中之任一者。In a twelfth aspect, the present application also discloses an organic light-emitting diode ("OLED") display including any of the previously disclosed films.
具體實施例 實施例1. 一種包含混合纖維素酯(「MCE」)之膜,其包含: (1)複數個乙醯基取代基; (2)複數個丁醯基取代基;及 (3)複數個羥基取代基, 其中: MCE對於乙醯基取代基的平均取代度(「DS Ac」)為0.9至2.4, MCE對於丁醯基取代基的平均取代度(「DS Bu」)為0.1至1.1, MCE對於羥基取代基的平均取代度(「DS OH」)為0.55至1.5。 Specific Examples Example 1. A film comprising mixed cellulose esters ("MCE") comprising: (1) a plurality of acetyl substituents; (2) a plurality of butyl substituents; and (3) a plurality of butyl substituents; Hydroxy substituent, wherein: MCE has an average degree of substitution for acetyl substituents ("DS Ac ") of 0.9 to 2.4, MCE has an average degree of substitution of butyl substituents ("DS Bu") of 0.1 to 1.1, MCE has an average degree of substitution of butyl substituents ("DS Bu ") of 0.1 to 1.1, The average degree of substitution of hydroxyl substituents ("DS OH ") is 0.55 to 1.5.
實施例2. 如實施例1之膜,其中DS Bu與DS Ac之和為2.0至2.4。 Embodiment 2. The film of embodiment 1, wherein the sum of DS Bu and DS Ac is 2.0 to 2.4.
實施例3. 如實施例1至2中任一項之膜,其中DS Bu為0.1至0.3。 Embodiment 3. The film of any one of embodiments 1 to 2, wherein DS Bu is 0.1 to 0.3.
實施例4. 如實施例1至3中任一項之膜,其中DS Ac為2.0至2.3。 Embodiment 4. The film of any one of embodiments 1 to 3, wherein DS Ac is 2.0 to 2.3.
實施例5. 如實施例1至4中任一項之膜,其中DS OH為0.6至0.7。 Embodiment 5. The membrane of any one of embodiments 1 to 4, wherein DS OH is 0.6 to 0.7.
實施例6. 如實施例1至5中任一項之膜,其中膜為反向色散四分之一波片。Embodiment 6. The film of any one of embodiments 1 to 5, wherein the film is a reverse dispersion quarter wave plate.
實施例7. 如實施例1至6中任一項之膜,其中膜展現: (i) 125 nm至145 nm範圍內之R e(550nm), (ii) -65 nm至-100 nm範圍內之R th(550nm), (iii) 0.85至0.98範圍內之R e(450nm)/R e(550nm), (iv) 1.07至0.96範圍內之R e(650nm)/R e(550nm), (v) 35微米至80微米之膜厚度(「d」),及 (vi)小於1%之混濁度%, 其中R e(450nm)、R e(550nm)及R e(650nm)分別為在450 nm、550 nm及650 nm之光波長下量測的平面內延遲,且R th(550nm)為在550 nm之光波長下量測的平面外延遲。 Embodiment 7. The film of any one of embodiments 1 to 6, wherein the film exhibits: (i) Re (550nm) in the range of 125 nm to 145 nm, (ii) -65 nm to -100 nm R th (550nm), (iii) Re (450nm)/R e (550nm) in the range of 0.85 to 0.98, (iv) Re (650nm)/ R e ( 550nm) in the range of 1.07 to 0.96, ( v) Film thickness ("d") of 35 microns to 80 microns, and (vi) Turbidity % less than 1%, where Re (450nm), Re (550nm) and Re (650nm) are respectively at 450nm nm, 550 nm, and 650 nm light wavelengths, and R th (550 nm) is the out-of-plane retardation measured at 550 nm light wavelengths.
實施例8. 如實施例1至7中任一項之膜,其中膜經單軸、雙軸或45度拉伸。Embodiment 8. The film of any one of embodiments 1 to 7, wherein the film is uniaxially, biaxially or 45 degree stretched.
實施例9. 如實施例1至8中任一項之膜,其中膜在加工方向(「MD」)上以0.7至1的比率及在橫向方向(「TD」)上以1至2的比率雙軸或45度拉伸。Embodiment 9. The film of any one of embodiments 1 to 8, wherein the film has a ratio of 0.7 to 1 in the machine direction ("MD") and a ratio of 1 to 2 in the transverse direction ("TD") Biaxial or 45 degree stretch.
實施例10. 如實施例1至9中任一項之膜,其中膜進一步包含5至25 wt%之包含芳族部分的增塑劑。Embodiment 10. The film of any one of embodiments 1 to 9, wherein the film further comprises 5 to 25 wt% of a plasticizer comprising an aromatic moiety.
實施例11. 如實施例10之膜,其中增塑劑為二((C 1-10)烷基)鄰苯二甲酸酯或磷酸三苯酯。 Embodiment 11. The film of Embodiment 10, wherein the plasticizer is di((C 1-10 )alkyl) phthalate or triphenyl phosphate.
實施例12. 如實施例1至11中任一項之膜,其中根據OECD 301F測試方法,膜在56天時展現至少40%可生物降解性。Embodiment 12. The film of any one of embodiments 1 to 11, wherein the film exhibits at least 40% biodegradability at 56 days according to OECD 301F test method.
實施例13. 一種反向色散四分之一波片,其包含: (A)混合纖維素酯(「MCE」),其包含: (1)複數個乙醯基取代基; (2)複數個丁醯基取代基;及 (3)複數個羥基取代基, 其中: MCE對於乙醯基取代基的平均取代度(「DS Ac」)為2.05至2.2, MCE對於丁醯基取代基的平均取代度(「DS Bu」)為0.18至0.25, MCE對於羥基取代基的平均取代度(「DS OH」)為0.54至0.6;及 (B) 5至25 wt%之增塑劑,其為二((C 1-10)烷基)鄰苯二甲酸酯或磷酸二苯酯, 其中膜展現: (i) 125 nm至145 nm範圍內之R e(550nm), (ii) -65 nm至-100 nm範圍內之R th(550nm), (iii) 0.85至0.98範圍內之R e(450nm)/R e(550nm), (iv) 1.07至0.96範圍內之R e(650nm)/R e(550nm), (v) 35微米至80微米之膜厚度(「d」),及 (vi)小於1%之混濁度%, 其中R e(450nm)、R e(550nm)及R e(650nm)分別為在450 nm、550 nm及650 nm之光波長下量測的平面內延遲,且R th(550nm)為在550 nm之光波長下量測的平面外延遲。 Example 13. A reverse dispersion quarter-wave plate comprising: (A) mixed cellulose ester ("MCE") comprising: (1) a plurality of acetyl substituents; (2) a plurality of acetyl substituents; Butylyl substituent; and (3) a plurality of hydroxyl substituents, wherein: the average degree of substitution of MCE for the acetyl substituent ("DS Ac ") is 2.05 to 2.2, and the average degree of substitution of MCE for the butyl substituent ("DS Bu ”) is 0.18 to 0.25, the average degree of substitution of MCE for hydroxyl substituents (“DS OH ”) is 0.54 to 0.6; and (B) 5 to 25 wt% plasticizer, which is two ((C 1- 10 ) Alkyl) phthalate or diphenyl phosphate, wherein the film exhibits: (i) R e (550 nm) in the range of 125 nm to 145 nm, (ii) -65 nm to -100 nm R th (550nm), (iii) Re (450nm)/R e (550nm) in the range of 0.85 to 0.98, (iv) Re (650nm)/ R e ( 550nm) in the range of 1.07 to 0.96, ( v) Film thickness ("d") of 35 microns to 80 microns, and (vi) Turbidity % less than 1%, where Re (450nm), Re (550nm) and Re (650nm) are respectively at 450nm nm, 550 nm, and 650 nm light wavelengths, and R th (550 nm) is the out-of-plane retardation measured at 550 nm light wavelengths.
實施例14. 如實施例13之膜,其中膜在加工方向(「MD」)上以0.7至1的比率及在橫向方向(「TD」)上以1至2的比率雙軸或45度拉伸。Embodiment 14. The film of Embodiment 13, wherein the film is biaxially or 45-degree stretched in the machine direction ("MD") at a ratio of 0.7 to 1 and in the transverse direction ("TD") at a ratio of 1 to 2 stretch.
實施例15. 如實施例13至14中任一項之膜,其中根據OECD 301F測試方法,膜在56天時展現至少40%可生物降解性。Embodiment 15. The film of any one of embodiments 13 to 14, wherein the film exhibits at least 40% biodegradability at 56 days according to OECD 301F test method.
實施例16. 一種有機發光二極體(「OLED」)顯示器,其包含如實施例1至15中任一項之膜。Embodiment 16. An organic light-emitting diode ("OLED") display comprising the film of any one of Embodiments 1 to 15.
實驗章節 縮寫 Ac 2O為乙酸酐;AcOH為乙酸;Biodeg為生物降解;CA-398-3為伊士曼(Eastman)乙酸纖維素398-3;CA-398-6為伊士曼乙酸纖維素398-6;CA-398-10為伊士曼乙酸纖維素398-10;CA-398-30為伊士曼乙酸纖維素398-30;CA-394-60LF為伊士曼乙酸纖維素394-60LF;CE為纖維素酯;CEx為比較例;℃為攝氏度;CAB為乙酸丁酸纖維素;CA為乙酸纖維素;DS為平均取代度;Ex為實例;DS Ac為乙醯基的平均取代度;DS Bu為丁醯基的平均取代度;DS OH為羥基的平均取代度;g為公克;h為小時;kg為公斤;Mg(OAc) 2為乙酸鎂;min為分鐘;mL為毫升;M w為重量平均分子量;OAc為乙酸酯;Pr 2O為丙酸酐;PrOH為丙酸;Pz為增塑劑;rt為室溫;soln為溶液;T g為玻璃轉化溫度;TXIB為伊士曼TXIB™調配物添加劑(三甲基戊基二異丁酸酯);VM234為伊士曼Visualize™材料234。 Experimental section abbreviation Ac 2 O is acetic anhydride; AcOH is acetic acid; Biodeg is biodegradation; CA-398-3 is Eastman cellulose acetate 398-3; CA-398-6 is Eastman cellulose acetate 398-6; CA-398-10 is Eastman cellulose acetate 398-10; CA-398-30 is Eastman cellulose acetate 398-30; CA-394-60LF is Eastman cellulose acetate 394- 60LF; CE is cellulose ester; CEx is a comparative example; ℃ is degrees Celsius; CAB is cellulose acetate butyrate; CA is cellulose acetate; DS is the average degree of substitution; Ex is an example; DS Ac is the average substitution of acetyl group degree; DS Bu is the average degree of substitution of butyl group; DS OH is the average degree of substitution of hydroxyl groups; g is grams; h is hour; kg is kilogram; Mg(OAc) 2 is magnesium acetate; min is minute; mL is milliliter; M w is the weight average molecular weight; OAc is acetate; Pr 2 O is propionic anhydride; PrOH is propionic acid; Pz is plasticizer; rt is room temperature; soln is solution; Tg is glass transition temperature; TXIB is EZ Man TXIB™ formulation additive (trimethylpentyl diisobutyrate); VM234 is Eastman Visualize™ Material 234.
製備乙酸丙酸纖維素 (Ex 1) (DS Ac=1.1, DS Pr=1.12, DS OH=0.78, M w=153777) 將活化纖維素混合物[纖維素(7.1份)及PrOH (11.0份)]在塔頂式攪拌下在容器中冷卻至15℃。隨後,在攪拌下將冷卻至15℃之硫酸(0.2份)、Ac 2O (11.3份)及Pr 2O (13.3份)之溶液(醯化溶液)添加至經冷卻活化纖維素混合物中。將所得反應混合物升溫至23℃且在23℃下攪拌60 min。接著經45 min將反應混合物加熱至63℃,此時添加PrOH (32.3份)及H 2O (11.3份)之溶液。接著將混合物在71℃下攪拌600 min。用Mg(OAc) 2.4H 2O (0.45份)於AcOH (7.3份)及H 2O (5.6份)中之溶液處理混合物,且將混合物攪拌30 min且冷卻至rt。過濾混合物。纖維素酯藉由水自濾液中沈澱且在商用摻合器中攪動,且過濾、收集纖維素酯,將固體用流動水洗滌且在設定為60℃之真空烘箱中乾燥直至乾燥,以獲得所需產物。 Preparation of cellulose acetate propionate (Ex 1) (DS Ac =1.1, DS Pr =1.12, DS OH =0.78, M w =153777) will be activated cellulose mixture [cellulose (7.1 parts) and PrOH (11.0 parts)] Cool to 15°C in the vessel with overhead stirring. Subsequently, a solution of sulfuric acid (0.2 parts), Ac 2 O (11.3 parts) and Pr 2 O (13.3 parts) cooled to 15°C (chelated solution) was added to the cooled activated cellulose mixture with stirring. The resulting reaction mixture was warmed to 23°C and stirred at 23°C for 60 min. The reaction mixture was then heated to 63°C over 45 min, at which time a solution of PrOH (32.3 parts) and H 2 O (11.3 parts) was added. The mixture was then stirred at 71 °C for 600 min. The mixture was treated with Mg(OAc) 2 .4H 2 O (0.45 parts) in AcOH (7.3 parts) and H 2 O (5.6 parts), and the mixture was stirred for 30 min and cooled to rt. Strain the mixture. The cellulose ester was precipitated from the filtrate by water and stirred in a commercial blender, and the cellulose ester was filtered and collected. The solid was washed with flowing water and dried in a vacuum oven set at 60°C until dry to obtain the desired Need products.
藉由調適用於製備乙酸丙酸纖維素1之程序,製備表1中之以下纖維素酯。
表1.
Ex 2 至 5、
7 至 8及
CEx 5之製備條件。
表2提供上文所製備之纖維素酯的屬性。
表2.
Ex 2 至 5、
7 至 8及
CEx 5之取代度及分子量。
製備乙酸丁酸纖維素 (Ex 6) (DS
Ac=2.17, DS
Bu=0.21, DS
OH=0.62 M
w=80,000 - 105,000)
活化纖維素混合物[纖維素(5.4份)及AcOH (21.5份)]以及一定量之硫酸在攪動反應器中冷卻至32℃。隨後,添加Ac
2O (11.3份)與Bu
2O (7.3份)之混合物,且將混合物在攪拌下冷卻至約9℃。添加總共0.4份之額外硫酸且將所得反應混合物升溫至55℃。將AcOH (23.3份)及H
2O (9.0份)之混合物添加至此反應混合物中。接著將混合物在68℃下攪拌495 min,但在80 min之後添加混合物Mg(OAc)
2(0.26份)、BuOH (8.7份)、AcOH (0.06份)及H
2O (3.8份)。在整個時間後,用Mg(OAc)
2(0.37份)、BuOH (1.9份)、AcOH (0.09份)及H
2O (6.7份)之溶液完全中和混合物。接著混合物沈澱於水中,藉由常見方法洗滌及乾燥。
表 3.
Ex 9 至 10及
CEx 6 至 7之製備條件。
生物降解 根據ISO 14851或OECD 301F方法,在水性好氧性生物降解測試中評估CE之生物降解。總測試期為約56天。測試在21℃±2℃下執行。使用伊士曼廢水處理淤渣作為接種物執行生物降解測試。 Biodegradable Biodegradation of CE is evaluated in the aqueous aerobic biodegradation test according to ISO 14851 or OECD 301F method. The total testing period is approximately 56 days. Testing is performed at 21℃±2℃. Biodegradation testing was performed using Eastman wastewater treatment sludge as inoculum.
在此測試中,CE分散於不含其他有機碳源之化學成分確定的礦物培養基中且接種來自廢水淤渣之微生物。當微生物在液態培養基中生物降解測試材料時,氧由微生物消耗,且來自測試材料之碳轉化成CO 2。在過程中產生之二氧化碳在瓶子內部由NaOH截留(NaOH置放於封閉式測試瓶子內部的箭袋中)且引起頂部空間中的壓降。此壓降直接對應於所消耗之氧,且因此對應於測試材料之生物降解。 In this test, CE is dispersed in a chemically defined mineral culture medium without other organic carbon sources and inoculated with microorganisms from wastewater sludge. When microorganisms biodegrade test materials in liquid culture media, oxygen is consumed by the microorganisms and carbon from the test materials is converted into CO2 . The carbon dioxide produced during the process is trapped inside the bottle by NaOH (NaOH is placed in a quiver inside the closed test bottle) and causes a pressure drop in the headspace. This pressure drop corresponds directly to the oxygen consumed, and therefore to the biodegradation of the test material.
在校正對照與測試物之理論需氧量之後,自耗氧量計算生物降解作為生物需氧量(BOD)之比。若材料在56天已達到參考材料之至少90%或90% (根據ISO 14851),則認為材料可生物降解。且根據ECHA微塑膠提議,若材料在60天已達到至少60%生物降解,則認為其可生物降解。
表 5 .提供
CEx 1 至 7及
Ex 1 至 10之淡水生物降解屬性。
製備微珠粒 製備程序 1程序1係基於EP0750007 (「EP'007」)中所揭示之程序。 Preparation of Microbeads Preparation Procedure 1 Procedure 1 is based on the procedure disclosed in EP0750007 ("EP'007").
乙酸丁酸纖維素微珠粒 7 ( 程序 1) Ex 6(40 g)、EtOAc (185 g)及EtOH (25 g)用於油相;且Benecel A4M (1.5 g)、Tween 28 (4.5 g)、水(350 g)及EtOAc (50 mL)用於水相。使用轉子-定子將水相以9000 rpm預混合5 min,且接著經20 min將油相添加至水相中。將所形成油狀乳液攪拌50 min,且經五分鐘在攪拌下將乳液經由200目篩網過濾至水(2500 mL)中。將所得混合物攪拌1 h。過濾所形成微粒。所得微粒用水洗滌且以10,000離心10 min,以自水相分離粒子(重複3次)。最終微粒展現1.21微米之D 10、4.96微米之D 50、12微米之D 90及0.646之多分散性,其藉由光散射來測定。D 10或D 50或D 90為粒度值,低於該等值時含有10%或50%或90%之材料。 Cellulose acetate butyrate microbeads 7 ( Procedure 1) Ex 6 (40 g), EtOAc (185 g) and EtOH (25 g) were used in the oil phase; and Benecel A4M (1.5 g), Tween 28 (4.5 g) , water (350 g) and EtOAc (50 mL) were used for the aqueous phase. The water phase was premixed using a rotor-stator at 9000 rpm for 5 min, and then the oil phase was added to the water phase over 20 min. The resulting oily emulsion was stirred for 50 min, and the emulsion was filtered through a 200 mesh screen into water (2500 mL) with stirring over five minutes. The resulting mixture was stirred for 1 h. Filter the particles formed. The resulting microparticles were washed with water and centrifuged at 10,000 for 10 min to separate the particles from the aqueous phase (repeated three times). The final particles exhibited a D10 of 1.21 microns, a D50 of 4.96 microns, a D90 of 12 microns, and a polydispersity of 0.646, as determined by light scattering. D 10 or D 50 or D 90 is the particle size value below which 10% or 50% or 90% of the material is contained.
製備程序 2 摻雜 體藉由將纖維素酯混合物(90 g)添加至乙酸乙酯、(C 2-3)烷醇、水混合物(547.7 g,80:13:7)同時以250 rpm攪拌來製備纖維素酯混合物之摻雜體。將所得混合物在rt下攪拌(約30 min)。 Preparation Procedure 2 Dopant was prepared by adding the cellulose ester mixture (90 g) to an ethyl acetate, (C 2-3 ) alkanol, water mixture (547.7 g, 80:13:7) while stirring at 250 rpm. Preparation of dopants of cellulose ester mixtures. The resulting mixture was stirred at rt (ca. 30 min).
乙酸丁酸纖維素/乙酸纖維素摻雜體製備
表4提供用於藉由
Ex 6製備代表性摻雜體之乙酸纖維素。表5展示哪些乙酸丁酸纖維素/乙酸纖維素摻雜體可能來自乙酸乙酯、乙醇及水溶液系統。藉由將CAB/CA (6.0 g)混合於溶劑[37.0 g (EA:EtOH:水,80:13:7)]中來製備摻雜體。
表6. 描述用於形成混合酯-乙酸纖維素微珠粒之乙酸纖維素材料。
表7提供由
Ex 6製成之摻雜體、各種乙酸纖維素或根據製備程序2中之摻雜程序的
Ex 6與各種乙酸纖維素之摻合物。僅某些乙酸纖維素可與
Ex 6摻合以在EA:EtOH:水溶劑系統中形成摻雜體,且所使用之乙酸纖維素中無一者能夠在EA:EtOH:水溶劑系統中形成摻雜體。
Ex 6易於在EA:EtOH:水溶劑系統中形成摻雜體。
表7. 使用EA:EtOH:水(80:13:7)溶劑系統之
Ex6及各種CA之摻雜體製備。
水性混合物藉由利用2級傾斜葉片攪動器(250 rpm)混合乙酸乙酯(124.6 g)與甲基纖維素(6.8 g)直至形成分散液為止來製備用於製備乳液之水性混合物。接著添加水(1280 g)及Tween-28 (13.5 g)。將所得水性混合物攪動約30 min,此時形成溶液。 Aqueous mixture The aqueous mixture used to prepare the emulsion was prepared by mixing ethyl acetate (124.6 g) and methylcellulose (6.8 g) using a 2-stage inclined blade stirrer (250 rpm) until a dispersion formed. Then add water (1280 g) and Tween-28 (13.5 g). The resulting aqueous mixture was stirred for approximately 30 min, at which time a solution formed.
用於形成珠粒之乳液 / 分散液方法以15 mL/min (約45 min)之速率將摻雜體(637.7 g)裝填至水性混合物(1424.3 g),同時攪拌(250 rpm)。隨後,將所得混合物以250 rpm攪動且在200 mL/min下經由MagicLab在線高剪切混合器(6000 rpm)再循環混合物30 min。 Emulsion / Dispersion Method for Bead Formation The dopant (637.7 g) was charged into the aqueous mixture (1424.3 g) at a rate of 15 mL/min (approximately 45 min) while stirring (250 rpm). Subsequently, the resulting mixture was stirred at 250 rpm and the mixture was recirculated via a MagicLab online high shear mixer (6000 rpm) at 200 mL/min for 30 min.
接著在攪拌(250 rpm)下以200 mL/min將混合物添加至水(5625 g)中,且在rt下將混合物攪動2 h。將混合物離心(3000 rpm,15 min)以分離珠粒。將珠粒用水洗滌且再離心(3000 rpm,15 min) (2次)。所得珠粒在100℃下在烘箱中以150 mmHg乾燥(16 h)。The mixture was then added to water (5625 g) with stirring (250 rpm) at 200 mL/min, and the mixture was stirred at rt for 2 h. The mixture was centrifuged (3000 rpm, 15 min) to separate the beads. The beads were washed with water and centrifuged again (3000 rpm, 15 min) (2 times). The resulting beads were dried in an oven at 100 °C at 150 mmHg (16 h).
表8提供使用程序2使用
Ex 6之摻合物以各種重量百分比之若干乙酸纖維素製成的微珠粒。
表8. 來自CA/CAb摻合物之微珠粒之製程結果
油耗量測 使用ASTM D281之測試方法「藉由刮刀擦除顏料之吸油量之標準測試方法」來量測吸收或油攝入屬性,使用礦物油而非蓖麻油。自MakingCosmetics.com公司獲得礦物油(項目編號ELL-MIOL-01)。 Fuel consumption measurement The absorption or oil uptake properties are measured using test method ASTM D281, "Standard Test Method for Oil Absorption of Pigments by Squeegee Ablation," using mineral oil rather than castor oil. Mineral oil (item number ELL-MIOL-01) was obtained from MakingCosmetics.com.
將礦物油逐滴添加至已知量之純粉末中,且用刮刀攪拌直至形成固體乾燥膏狀物為止。當形成固體乾燥膏狀物時,不再吸收礦物油。一旦測定油量,則使用下式計算油耗: OT = (100 x V oil)/m sampleOT:油耗(mL/100 g);V oil:所使用之油之體積(mL);m sample:樣本之質量(g) Mineral oil is added dropwise to a known amount of pure powder and stirred with a spatula until a solid dry paste forms. When a solid dry paste forms, mineral oil is no longer absorbed. Once the oil volume is measured, the following formula is used to calculate the oil consumption: OT = (100 x V oil )/m sample OT: oil consumption (mL/100 g); V oil : volume of oil used (mL); m sample : sample The mass (g)
結果展示於表4中。
表9.
製備膜 本文中所揭示之纖維素混合酯適用於製備諸如光學膜之膜。表10提供由例示性纖維素混合酯形成之數個膜。 Prepare membrane The cellulose mixed esters disclosed herein are suitable for use in the preparation of films such as optical films. Table 10 provides several films formed from exemplary cellulose mixed esters.
膜自12 wt%固體摻雜體之纖維素混合酯、增塑劑及溶劑(二氯甲烷/(甲醇或乙醇))溶劑澆鑄。在摻雜體澆鑄至玻璃板上後,覆蓋澆鑄摻雜體以允許經45分鐘進行受控的溶劑蒸發。接著,移除覆蓋物以允許15分鐘之繼續溶劑蒸發。自玻璃板剝離膜,且在紙之間以一定重量乾燥膜2小時以避免膜在乾燥製程期間捲曲。接著將膜切割成一定大小且在金屬框架之間乾燥,且各自置放於100℃及120℃下10分鐘。對於經拉伸膜,使用Brueckner Kario IV。使用J.A. Woollam光譜橢圓偏光儀利用CompleteEase分析軟體量測膜之光學屬性。
表10.
膜 1.1至
1.4及
2.1至
2.6。
表12提供
膜 2.7至
2.10之穩定性研究。
膜 2.7及
2.9為不在60℃下在100% RH下經處理之彼等膜。
膜 2.8及
2.10在60℃下在100% RH下處理144小時。用DEP、芳族增塑劑塑化且經歷熱及濕度條件144小時之膜(膜2.10)比用CHDM、非芳香族增塑劑塑化且經歷熱及濕度條件144小時之彼等膜更穩定。具體而言,CHDM塑化膜展現大Re、Rth及混濁度%變化,而藉由DEP塑化之膜展現極小變化。
表12.
出於說明及描述之目的,已呈現本發明之各種實施例之前述描述。其並不意欲為詳盡的或將本發明限制於所揭示之精確實施例。鑒於上述教示,眾多修改或變化為可能的。選擇及描述所論述的實施例以提供對本發明原理及其實際應用的最佳說明,藉此使得一般熟習此項技術者能夠在各種實施例中並且用適合於所預期特定用途的各種修改來利用本發明。所有此等修改及變化均在由所附申請專利範圍(在根據其公平、合法並且正當授權之廣度來進行解釋時)所判定之本發明之範疇內。The foregoing description of various embodiments of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise embodiments disclosed. Numerous modifications or variations are possible in light of the above teachings. The embodiments discussed were chosen and described in order to provide the best explanation of the principles of the invention and its practical application, thereby enabling others of ordinary skill in the art to utilize it in various embodiments and with various modifications as are suited to the particular use contemplated. invention. All such modifications and variations are within the scope of the invention as determined by the scope of the appended claims (when construed in accordance with their fair, legal and properly authorized breadth).
Claims (16)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163263952P | 2021-11-12 | 2021-11-12 | |
US63/263,952 | 2021-11-12 | ||
US202163264990P | 2021-12-06 | 2021-12-06 | |
US63/264,990 | 2021-12-06 | ||
US202263365202P | 2022-05-24 | 2022-05-24 | |
US63/365,202 | 2022-05-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202336123A true TW202336123A (en) | 2023-09-16 |
Family
ID=84602273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW111143168A TW202336123A (en) | 2021-11-12 | 2022-11-11 | Freshwater biodegradable mixed ester cellulose esters |
Country Status (2)
Country | Link |
---|---|
TW (1) | TW202336123A (en) |
WO (5) | WO2023086529A1 (en) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56162617A (en) | 1980-05-20 | 1981-12-14 | Fuji Photo Film Co Ltd | Preparation of film |
DE19522181C2 (en) | 1995-06-19 | 1999-06-24 | Fraunhofer Ges Forschung | Process for the production of spherical microparticles based on cellulose acetate or cellulose |
US7470384B2 (en) | 2001-06-15 | 2008-12-30 | Fujifilm Corporation | Method of producing of cellulose ester film |
JP4280486B2 (en) | 2002-11-25 | 2009-06-17 | 富士フイルム株式会社 | Solution casting method |
US20090096962A1 (en) | 2007-05-14 | 2009-04-16 | Eastman Chemical Company | Cellulose Esters with High Hyrdoxyl Content and Their Use in Liquid Crystal Displays |
CN101796104B (en) | 2007-08-24 | 2014-02-19 | 伊士曼化工公司 | Mixed cellulose ester compositions comprising a plasticizer and having low bifringence and films made therefrom for liquid crystal displays |
JP5222064B2 (en) | 2008-09-02 | 2013-06-26 | 富士フイルム株式会社 | Cellulose acylate laminated film, production method thereof, polarizing plate and liquid crystal display device |
US20140168770A1 (en) * | 2010-07-02 | 2014-06-19 | Eastman Chemical Company | Multilayer and single layer cellulose ester films having reversed optical dispersion |
WO2012124514A1 (en) * | 2011-03-11 | 2012-09-20 | コニカミノルタアドバンストレイヤー株式会社 | Cellulose ester film, and polarizer and liquid-crystal display device both equipped therewith |
KR20160101159A (en) * | 2014-01-24 | 2016-08-24 | 코니카 미놀타 가부시키가이샤 | Phase difference film, polarizing plate, and va-type liquid crystal display |
JP7149885B2 (en) | 2019-03-22 | 2022-10-07 | 株式会社ダイセル | Cellulose derivative particles, cosmetic composition, and method for producing cellulose derivative particles |
-
2022
- 2022-11-11 WO PCT/US2022/049642 patent/WO2023086529A1/en unknown
- 2022-11-11 TW TW111143168A patent/TW202336123A/en unknown
- 2022-11-11 WO PCT/US2022/049641 patent/WO2023086528A1/en unknown
- 2022-11-11 WO PCT/US2022/049643 patent/WO2023086530A1/en unknown
- 2022-11-11 WO PCT/US2022/049644 patent/WO2023086531A1/en unknown
- 2022-11-11 WO PCT/US2022/049645 patent/WO2023086532A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2023086532A1 (en) | 2023-05-19 |
WO2023086529A1 (en) | 2023-05-19 |
WO2023086530A1 (en) | 2023-05-19 |
WO2023086528A1 (en) | 2023-05-19 |
WO2023086531A1 (en) | 2023-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070088099A1 (en) | Use of an aqueous dispersion of at least one biodegradable polymer containing at least one stabilizing agent for the preparation of an aqueous filmogenic composition | |
TWI433881B (en) | A cellulose-based resin composition and a cellulose-based resin film | |
US20230045673A1 (en) | Biodegradable compositions and articles made from cellulose acetate | |
US20230075066A1 (en) | Biodegradable compositions and articles made from cellulose acetate | |
US20230183449A1 (en) | Biodegradable compositions and articles made from cellulose acetate | |
JP7328901B2 (en) | Multilayer antifogging composition and method of making same | |
EP4373863A1 (en) | Melt-processable, biodegradable cellulose acetates, compositions, melts and melt-formed articles made therefrom | |
RU2447101C2 (en) | Composition of at least one vinylidene chloride polymer | |
TW202248330A (en) | Thermoformed articles made from bio-based polymers and compositions therefore | |
TW202336123A (en) | Freshwater biodegradable mixed ester cellulose esters | |
WO2023059849A1 (en) | Process for making melt processable cellulose ester compositions comprising amorphous biofiller | |
WO2023034473A1 (en) | Cellulose acetate foams | |
CN118234757A (en) | Biodegradable mixed ester cellulose esters in fresh water | |
CN118234756A (en) | Biodegradable microbeads from mixed cellulose esters | |
CN118265728A (en) | Biodegradable mixed ester cellulose esters in fresh water | |
CN118265729A (en) | Biodegradable mixed ester cellulose esters in fresh water | |
US20220235202A1 (en) | Cellulose resin composition, molded body and product using same | |
WO2023159002A1 (en) | Melt-processable cellulose ester compositions, melts and melt-formed articles made therefrom | |
JP5456471B2 (en) | Method for producing vinylidene chloride polymer composition and film and packaging obtained from the composition | |
EP4373887A1 (en) | Foamable cellulose acetate compositions, foams and foam articles formed therefrom | |
WO2023059853A1 (en) | Articles containing melt processable cellulose ester compositions comprising amorphous biofiller | |
WO2023034472A1 (en) | Melt-processable cellulose acetate compositions, melts and melt-formed articles made therefrom | |
CN118076680A (en) | Melt-processible cellulose ester compositions comprising amorphous biofilm |